CARDINAL HEALTH INC - 10-K - 20050912 - EXHIBIT_10
Exhibit 10.21
RESTRICTED SHARE UNITS AGREEMENT
On _____________ (the "Grant Date"), Cardinal Health, Inc, an Ohio
corporation (the "Company"), has granted to _________ ("Grantee") ________
Restricted Share Units (the "Restricted Share Units" or "Award"), representing
an unfunded unsecured promise of the Company to deliver common shares, without
par value, of the Company (the "Common Shares") to Grantee as set forth herein.
The Restricted Share Units have been granted pursuant to the Cardinal Health,
Inc. Amended and Restated Equity Incentive Plan, as amended (the "Plan"), and
shall be subject to all provisions of the Plan, which are incorporated herein by
reference, and shall be subject to the provisions of this Restricted Share Units
Agreement (this "Agreement"). In the event of a conflict between the provisions
of this Agreement and the provisions of the Plan, the provisions of the Plan
shall control. Capitalized terms used in this Agreement which are not
specifically defined shall have the meanings ascribed to such terms in the Plan.
1. VESTING. Subject to the provisions set forth elsewhere in this
agreement, the Restricted Share Units shall vest in accordance with the
following schedule: [percentage of Restricted Share Units vesting on each
applicable anniversary of the Grant Date] (each such vesting date, the "Vesting
Date" with respect to the Restricted Share Units scheduled to vest on such
date).
2. PURCHASE PRICE. The purchase price of the Restricted Share Units shall
be $0.00.
3. TRANSFERABILITY. The Restricted Share Units shall not be transferable.
4. TERMINATION OF SERVICE. Unless otherwise determined by the Committee at
or after grant or termination, and except as set forth below, if Grantee's
Continuous Service (as hereinafter defined) to the Company and its subsidiaries
(collectively, the "Cardinal Group") terminates prior to the Vesting Date, with
respect to an unvested Restricted Share Unit, such Restricted Share Unit shall
be forfeited by Grantee. If Grantee's Continuous Service terminates prior to the
vesting in full of the Restricted Share Units by reason of Grantee's death or
disability (as defined in the Plan), then the restrictions with respect to a
ratable portion of any unvested Restricted Share Units shall lapse and such
ratable portion shall not be forfeited. Such ratable portion shall be determined
separately with respect to the Restricted Share Units scheduled to vest on each
applicable Vesting Date, and shall be an amount equal to the number of
Restricted Share Units scheduled to vest on such Vesting Date multiplied by a
fraction, the numerator of which is the number of days from the Grant Date
through the date of such death or disability, and the denominator of which is
the number of days from the Grant Date through such Vesting Date. For purposes
of this Agreement, the term "Continuous Service" shall mean the absence of any
interruption or termination of service as an employee or director of any entity
within the Cardinal Group.
5. AGREEMENT NOT TO DISCLOSE OR USE CONFIDENTIAL INFORMATION, TRADE SECRETS
OR OTHER BUSINESS SENSITIVE INFORMATION. The parties acknowledge and agree that
the Cardinal Group is the sole and exclusive owner of Confidential Information,
Trade Secrets or Other Business Sensitive Information (as hereinafter defined)
and that the Cardinal Group has
legitimate business interests in protecting such information. The parties
further acknowledge and agree that the Cardinal Group has invested, and
continues to invest, considerable amounts of time and money in obtaining,
developing and preserving the confidentiality of such information. Further, the
parties agree that, because of the trust and fiduciary relationship arising
between Grantee and the Cardinal Group, Grantee owes the Cardinal Group a
fiduciary duty to preserve and protect such information from any and all
unauthorized disclosure and use. Accordingly, Grantee shall not, either directly
or indirectly, disclose such information to any third party whatsoever and shall
not use such information in any manner, except as authorized in the reasonable
performance of Grantee's duties while employed by the Cardinal Group.
"Confidential Information, Trade Secrets or Other Business Sensitive
Information" shall include any such information as defined by applicable law and
any information about the business of the Cardinal Group and its customers that
is not generally known to, or readily ascertainable by, the public, including,
but not limited to, financial information and models, customer lists, business
plans or strategies, marketing and sales plans or strategies, the identity,
compensation and qualifications of employees of the Cardinal Group, sources of
supply, pricing policies, operational methods, product specification or
technical processes, new product information, formulation techniques, customer
contacts, profit or cost information, research and development information or
other information that the Cardinal Group has developed or compiled.
6. DELIVERY OF COMPANY PROPERTY. Grantee recognizes and agrees that all
documents, magnetic media, computer disks, desktop and laptop computers and
other tangible items that were provided by the Cardinal Group and/or that
contain Confidential Information, Trade Secrets or Other Business Sensitive
Information as defined above are the sole and exclusive property of the Cardinal
Group. Upon request by the Cardinal Group, Grantee shall promptly and
immediately return to the Cardinal Group all such documents, media, disks,
desktop and laptop computers and other tangible items. Upon the termination of
Grantee's employment with the Cardinal Group, Grantee shall promptly and
immediately return to the Cardinal Group any and all such documents, media,
disks, desktop and laptop computers or other tangible items, without request by
the Cardinal Group. Grantee shall not take any such information or make/retain
copies of such information for any purpose whatsoever except as is necessary for
the reasonable performance of Grantee's duties while employed by the Cardinal
Group.
7. OTHER COVENANTS. Except as modified by Paragraph 11 below, Grantee
hereby covenants and agrees that, in consideration of the grant hereunder,
Grantee shall not, either directly or indirectly, on Grantee's own behalf or on
any other's behalf, engage in or assist others in any of the following
activities:
(a) Grantee shall not engage in any action or conduct that is a
violation of the policies of the Cardinal Group, including conduct that
would constitute a breach of any of the Certificates of Compliance with
Company Policies and/or the Certificates of Compliance with Company
Business Ethics Policies executed by Grantee;
(b) During Grantee's employment with the Cardinal Group and for 12
months following the termination of such employment for any reason, Grantee
shall not, either directly or indirectly, employ, contact concerning
employment, or participate in any
2
manner in the recruitment for employment of (whether as an employee,
officer, director, agent, consultant or independent contractor), any person
who was or is an employee, representative, officer or director of the
Cardinal Group at any time within the 12 months prior to the termination of
Grantee's employment with the Cardinal Group;
(c) Grantee shall not at any time during employment with the Cardinal
Group nor at any time thereafter disparage the Cardinal Group or any of its
employees, officers, representatives, services or products;
(d) During Grantee's employment with the Cardinal Group and for 12
months following the termination of such employment for any reason, Grantee
shall not engage in any action or conduct that either does or could
reasonably be expected to undermine, diminish or otherwise damage the
relationship between the Cardinal Group and any of its customers, potential
customers, vendors or suppliers that were known to Grantee in the
performance of Grantee's job duties while employed with the Cardinal Group;
(e) During Grantee's employment with the Cardinal Group and for 12
months following the termination of such employment for any reason, Grantee
shall not solicit or accept business of the same type as that in which
Grantee was employed by the Cardinal Group from any customer, potential
customer, vendor or supplier of the Cardinal Group that was known to
Grantee in the performance of Grantee's job duties while employed with the
Cardinal Group, nor shall Grantee during such time period solicit or accept
such business within any geographic area in which Grantee was assigned or
for which Grantee had any managerial responsibility;
(f) During Grantee's employment with the Cardinal Group and for 12
months following the termination of such employment for any reason, Grantee
shall not accept employment with or serve as a consultant or advisor or in
any other capacity to an entity that is in competition with the business
conducted by any member of the Cardinal Group within a geographic area in
which Grantee was assigned or for which Grantee had any managerial
responsibility; and
(g) Grantee shall not breach or violate any provision of any
employment or severance agreement that Grantee has with any member of the
Cardinal Group.
8. INEVITABLE DISCLOSURE. The parties specifically acknowledge and agree
that the provisions of this Agreement are reasonable in light of the fact that,
in the event that Grantee would become employed or otherwise associated with a
competitor of the Cardinal Group, it would be inevitable that Grantee would
disclose Confidential Information, Trade Secrets or Other Business Sensitive
Information as defined above to such competitor. The parties acknowledge and
agree that Grantee has been introduced by the Cardinal Group to such
Confidential Information, Trade Secrets or Other Business Sensitive Information
as defined above and that such information would aid the competitor and that the
threat of such inevitable disclosure is so great that, for purposes of this
Agreement, it must be assumed that such disclosure would occur.
3
9. COVENANTS ARE INDEPENDENT ELEMENTS. The parties acknowledge that the
obligations and covenants set forth in Paragraphs 5 through 8 above and, if
applicable, Paragraph 11 below are essential independent elements of this
Restricted Share grant and that, but for Grantee agreeing to comply with them,
the Cardinal Group would not have granted such Restricted Share Units to
Grantee. The parties agree and acknowledge that the provisions contained in
Paragraphs 5 through 8 above and, if applicable, Paragraph 11 below are
ancillary to, or part of, an otherwise enforceable agreement at the time the
agreement is made with regard to such paragraphs. The existence of any claim by
Grantee against the Cardinal Group, whether based on this Agreement or
otherwise, shall not operate as a defense to the enforcement of the covenants
contained in Paragraphs 5 through 8 above and, if applicable, Paragraph 11
below. The covenants contained in Paragraphs 5 through 8 above and, if
applicable, Paragraph 11 below will remain in full force and effect whether
Grantee is terminated by the Cardinal Group or voluntarily resigns.
10. ASSIGNMENT OF COVENANTS. The rights of the Cardinal Group under this
Agreement shall inure to the benefit of, and be binding upon, its successors and
assigns. Any successor or assign of the Cardinal Group is authorized to enforce
the covenants contained in this Agreement. Any successor or assign of the
Cardinal Group is authorized by the parties to enforce the covenants contained
herein as if the name of such successor or assign shall replace the Cardinal
Group throughout this Agreement and any consent and/or notice, written or
otherwise, is hereby waived and deemed unnecessary by Grantee.
11. CALIFORNIA SPECIFIC MODIFICATIONS. This paragraph shall supercede and
modify certain of the covenants, obligations and restrictions of Grantee set
forth in Paragraph 7 above in the event that, and only during such time that,
Grantee's principal employment with the Cardinal Group is in the State of
California. In the event that any of the provisions contained in Subparagraphs
7(d) through (f) above are inconsistent with the provisions of this Paragraph 11
with regard to the State of California, then the provisions contained in
Subparagraphs 7(d) through (f) shall not apply and the following provisions
shall apply instead:
(a) Within the geographic area in which Grantee was assigned or for
which Grantee had any managerial responsibility, Grantee shall not, during
Grantee's employment with the Cardinal Group and for 12 months following
termination of such employment for any reason, solicit or actually transact
business with any existing customer of the Cardinal Group of which
Grantee's knowledge of the existence of that customer or of that customer's
purchasing habits, product preferences or commercial practices exists
because of Grantee's receipt of Confidential Information, Trade Secrets or
Other Business Sensitive Information from the Cardinal Group; and
(b) Regardless of geographic area, Grantee shall not, during the
period of Grantee's employment with the Cardinal Group and for 12 months
following termination of such employment for any reason, solicit business
from any customers of the same type as the business of the Cardinal Group
at the time of the termination of Grantee's employment with the Cardinal
Group whose identities are not already within the public
4
domain if Grantee directly serviced such customers, was assigned to such
customers, was responsible for such customers or otherwise had personal
contact with such customers during the 12-month period immediately
preceding expiration of Grantee's employment with the Cardinal Group.
In the event that Grantee is reassigned to any other state within the United
States of America other than the State of California or to any other country,
then all of the provisions of Paragraph 7 above shall apply in full force and
effect and the provisions of this Paragraph 11 shall not apply.
12. REASONABLENESS OF RESTRICTIONS CONTAINED IN AGREEMENT. Grantee
acknowledges that the covenants contained in this Agreement are reasonable in
nature, are fundamental for the protection of the legitimate business and
proprietary interests of the Cardinal Group, are necessary to protect the
goodwill between the Cardinal Group and its customers, and do not adversely
affect Grantee's ability to earn a living in any capacity that does not violate
such covenants. The parties further agree that in the event of any violation by
Grantee of any such covenants, the Company will suffer immediate and irreparable
injury for which there is no adequate remedy at law.
13. SPECIAL FORFEITURE/REPAYMENT RULES. If Grantee engages in conduct that
is in violation of the covenants and restrictions contained in this Agreement,
then Grantee shall be subject to the following special forfeiture/repayment
rules in addition to any other remedy that the Cardinal Group may have:
(a) any Restricted Share Units that have not yet vested or that vested
within the Look-Back Period (as defined below) with respect to such conduct
that is in violation of the covenants and restrictions contained in this
Agreement and have not yet been settled by a payment pursuant to Paragraph
14 hereof shall immediately and automatically terminate, be forfeited, and
cease to exist; and
(b) Grantee shall, within 30 days following written notice from the
Company, pay to the Company an amount equal to (x) the aggregate gross gain
realized or obtained by Grantee resulting from the settlement of all
Restricted Share Units pursuant to Paragraph 7 hereof (measured as of the
settlement date (i.e., the market value of the Restricted Share Units on
such settlement date)) that have already been settled and that had vested
at any time within three years prior to the conduct by Grantee that is in
violation of the covenants and restrictions contained in this Agreement
(the "Look-Back Period"), minus (y) $1.00.
Grantee may be released from Grantee's obligations under this Paragraph 13
if and only if the Committee (or its duly appointed designee) determines, in
writing and in its sole discretion, that such action is in the best interests of
the Company. Grantee agrees to provide the Company with at least 10 days written
notice prior to directly or indirectly accepting employment with or serving as a
consultant or advisor or in any other capacity to a competitor, and further
agrees to inform any such new employer, before accepting employment, of the
terms of this Agreement and Grantee's continuing obligations contained herein.
No provision of this Agreement shall diminish, negate or otherwise impact any
separate noncompete or other agreement to which
5
Grantee may be a party, including, but not limited to, any of the Certificates
of Compliance with Company Policies and/or the Certificates of Compliance with
Company Business Ethics Policies; provided, however, that to the extent that any
provisions contained in any other agreement are inconsistent in any manner with
the restrictions and covenants of Grantee contained in this Agreement, the
provisions of this Agreement shall take precedence and such other inconsistent
provisions shall be null and void. Grantee acknowledges and agrees that the
restrictions and covenants of Grantee contained in this Agreement are being made
for the benefit of the Company in consideration of Grantee's receipt of the
Restricted Share Units, in consideration of employment, in consideration of
exposing Grantee to the Company's business operations and confidential
information, and for other good and valuable consideration, the adequacy of
which consideration is hereby expressly confirmed. Grantee further acknowledges
that the receipt of the Restricted Share Units and execution of this Agreement
are voluntary actions on the part of Grantee and that the Company is unwilling
to provide the Restricted Share Units to Grantee without including the
restrictions and covenants of Grantee contained in this Agreement. Further, the
parties agree and acknowledge that the provisions contained in Paragraph 7 and,
if applicable, Paragraph 11 are ancillary to, or part of, an otherwise
enforceable agreement at the time the agreement is made.
14. PAYMENT. Subject to the provisions of Paragraphs 5 through 8 and, if
applicable, Paragraph 11, of this Agreement, on the [VESTING PAYMENT
ALTERNATIVE: date of vesting of any] [DEFERRED PAYMENT ALTERNATIVE:
[___-month][___-year] anniversary of the first date on which Grantee ceases to
be an employee of the Company, or, to the extent permitted by Treasury
Regulations, on such other date as may be approved by the Committee as to all or
any portion of the] Restricted Share Units, Grantee shall be entitled to receive
from the Company (without any payment on behalf of Grantee other than as
described in Paragraph 17) the Common Shares represented by such Restricted
Share Units [DEFERRED PAYMENT ALTERNATIVE: ;provided, however, that, subject to
the next sentence, in the event that some or all of the Restricted Share Units
vest prior to the applicable Vesting Date as a result of the death or disability
of Grantee or as a result of a Change of Control, Grantee shall be entitled to
receive the corresponding Common Shares from the Company on the date of such
vesting. Notwithstanding the proviso of the preceding sentence, if Restricted
Share Units vest as a result of the occurrence of a disability or a Change of
Control under circumstances where such occurrence would not qualify as a
permissible date of distribution under Section 409A(a)(2)(A) of the Internal
Revenue Code of 1986, as amended (the "Code"), and the regulations thereunder,
such proviso shall not apply and Grantee shall be entitled to receive the
corresponding Common Shares from the Company on the date that would have applied
absent such proviso]. Elections to defer receipt of the Common Shares beyond the
date of settlement provided herein may be permitted in the discretion of the
Committee pursuant to procedures established by the Committee in compliance with
the requirements of Section 409A of the [VESTING PAYMENT ALTERNATIVE: Internal
Revenue Code of 1986, as amended] [DEFERRED PAYMENT ALTERNATIVE: Code].
15. DIVIDENDS. Grantee shall not receive cash dividends on the Restricted
Share Unit but instead shall, with respect to each Restricted Share Unit,
receive a cash payment from the Company on each cash dividend payment date with
respect to the Common Shares with a record date between the Grant Date and the
earlier of the forfeiture of such unit in accordance with the
6
terms hereof or the settlement of such unit pursuant to Paragraph 14 hereof,
such cash payment to be in an amount equal to the dividend that would have been
paid on the Common Share represented by such unit.
15. RIGHT OF SET-OFF. By accepting these Restricted Share Units, Grantee
consents to a deduction from, and set-off against, any amounts owed to Grantee
by any member of the Cardinal Group from time to time (including, but not
limited to, amounts owed to Grantee as wages, severance payments or other fringe
benefits) to the extent of the amounts owed to the Cardinal Group by Grantee
under this Agreement.
16. NO SHAREHOLDER RIGHTS. Grantee shall have no rights of a shareholder
with respect to the Restricted Share Units, including, without limitation,
Grantee shall not have the right to vote the Common Shares represented by the
Restricted Share Units.
17. WITHHOLDING TAX. The Company shall have the right to require Grantee to
pay to the Company the amount of any taxes which the Company is required to
withhold with respect to the Restricted Share Units (including the amount of any
taxes which the Company is required to withhold with respect to the cash
payments described in Paragraph 15 hereof) or, in lieu thereof, to retain, or
sell without notice, a sufficient number of Common Shares to cover the amount
required to be withheld. In the case of any amounts withheld for taxes pursuant
to this provision in the form of Common Shares, the amount withheld shall not
exceed the minimum required by applicable law and regulations. The Company shall
have the right to deduct from all cash payments paid pursuant to Paragraph 15
hereof the amount of any taxes which the Company is required to withhold with
respect to such payments.
18. BENEFICIARY DESIGNATION. Grantee may designate a beneficiary to receive
any Common Shares to which the Grantee is entitled with respect to the
Restricted Share Units which vest as a result of Grantee's death.
Notwithstanding the foregoing, if Grantee engages in conduct that is in
violation of the covenants and restrictions contained in this Agreement, the
Restricted Share Units subject to such beneficiary designation shall be subject
to the Special Forfeiture/Repayment Rules and the Company's Right of Set-Off or
other right of recovery set forth in this Agreement, and all rights of the
beneficiary shall be subordinated to the rights of the Company pursuant to such
provisions of this Agreement. Grantee acknowledges that the Company may exercise
all rights under this Agreement and the Plan against Grantee and Grantee's
estate, heirs, lineal descendants and personal representatives and shall not be
limited to exercising its rights against Grantee's beneficiary.
19. GOVERNING LAW/VENUE. This Agreement shall be governed by the laws of
the State of Ohio, without regard to principles of conflicts of law, except to
the extent superseded by the laws of the United States of America. The parties
agree and acknowledge that the laws of the State of Ohio bear a substantial
relationship to the parties and/or this Agreement and that the Restricted Share
Units and benefits granted herein would not be granted without the governance of
this Agreement by the laws of the State of Ohio. In addition, all legal actions
or proceedings relating to this Agreement shall be brought in state or federal
courts located in Franklin County, Ohio, and the parties executing this
Agreement hereby consent to the personal jurisdiction of such courts. In the
event of any violation or attempted violations of the restrictions and
7
covenants of Grantee contained in this Agreement, the Cardinal Group shall be
entitled to specific performance and injunctive relief or other equitable
relief, including the issuance ex parte of a temporary restraining order,
without any showing of irreparable harm or damage, such irreparable harm being
acknowledged and admitted by Grantee, and Grantee hereby waives any requirement
for the securing or posting of any bond in connection with such remedy, without
prejudice to the rights and remedies afforded the Cardinal Group hereunder or by
law. In the event that it becomes necessary for the Cardinal Group to institute
legal proceedings under this Agreement, Grantee shall be responsible to the
Company for all costs and reasonable legal fees incurred by the Company with
regard to such proceedings.
20. SEVERABILITY. It is the desire and intent of the parties that the
provisions of this Agreement shall be enforced to the fullest extent permissible
under the laws and public policies applied in each jurisdiction in which
enforcement is sought. Accordingly, if any particular provision or portion of
this Agreement shall be determined by a court of competent jurisdiction to be
invalid or unenforceable as written, it is the intent and desire of the parties
that the court shall modify the language of such provision or portion of this
Agreement to the extent necessary to make it valid and enforceable. If no such
modification by the court is possible, this Agreement shall be deemed amended to
delete therefrom only the provision or portion thus determined to be invalid or
unenforceable. Such modification or deletion is to apply only with respect to
the operation of such provision in the particular jurisdiction in which such
court determination is made.
21. ACTION BY THE COMMITTEE. The parties agree that the interpretation of
this Agreement shall rest exclusively and completely within the sole discretion
of the Committee. The parties agree to be bound by the decisions of the
Committee with regard to the interpretation of this Agreement and with regard to
any and all matters set forth in this Agreement. The Committee may delegate its
functions under this Agreement to an officer of the Cardinal Group designated by
the Committee (hereinafter the "Designee"). In fulfilling its responsibilities
hereunder, the Committee or its Designee may rely upon documents, written
statements of the parties or such other material as the Committee or its
Designee deems appropriate. The parties agree that there is no right to be heard
or to appear before the Committee or its Designee and that any decision of the
Committee or its Designee relating to this Agreement, including, without
limitation, whether particular conduct constitutes a violation of the covenants,
obligations and restrictions of Grantee set forth in Paragraphs 5 through 7 and,
if applicable, Paragraph 11 above, shall be final and binding unless such
decision is arbitrary and capricious.
22. PROMPT ACCEPTANCE OF AGREEMENT. The Restricted Share Units grant
evidenced by this Agreement shall, at the discretion of the Committee, be
forfeited if this Agreement is not executed by Grantee and returned to the
Company within 30 days of the Grant Date set forth below.
23. ELECTRONIC DELIVERY. The Company may, in its sole discretion, decide to
deliver any documents related to the Restricted Share Units grant under and
participation in the Plan or future Restricted Share Units that may be granted
under the Plan by electronic means or to request Grantee's consent to
participate in the Plan by electronic means. Grantee hereby consents to receive
such documents by electronic delivery and, if requested, to participate in the
8
Plan through an on-line or electronic system established and maintained by the
Company or another third party designated by the Company.
CARDINAL HEALTH, INC.
DATE OF GRANT: By:
---------------------- ------------------------------------
Its:
-----------------------------------
9
ACCEPTANCE OF AGREEMENT
Grantee hereby: (a) acknowledges that he or she has received a copy of the Plan,
a copy of the Company's most recent Annual Report on Form 10-K and other
communications routinely distributed to the Company's shareholders, and a copy
of the Plan Description dated ____________ pertaining to the Plan; (b) accepts
this Agreement and the Restricted Share Units granted to him or her under this
Agreement subject to all provisions of the Plan and this Agreement; (c)
represents and warrants to the Company that he or she is purchasing the
Restricted Share Units for his or her own account, for investment, and not with
a view to or any present intention of selling or distributing the Restricted
Share Units either now or at any specific or determinable future time or period
or upon the occurrence or nonoccurrence of any predetermined or reasonably
foreseeable event; and (d) agrees that no transfer of the Common Shares
delivered in respect of the Restricted Share Units shall be made unless the
Common Shares have been duly registered under all applicable Federal and state
securities laws pursuant to a then-effective registration which contemplates the
proposed transfer or unless the Company has received a written opinion of, or
satisfactory to, its legal counsel that the proposed transfer is exempt from
such registration.
Grantee's Signature
Grantee's Social Security Number
Date
10
Exhibit 10.23
CARDINAL HEALTH, INC.
AMENDED AND RESTATED
OUTSIDE DIRECTORS EQUITY INCENTIVE PLAN
SECTION 1 | PURPOSE
The purpose of the Cardinal Health, Inc. Amended and Restated Outside Directors
Equity Incentive Plan (the "Plan") is to assist Cardinal Health, Inc. (the
"Company") in attracting and retaining qualified members of its Board of
Directors. The Plan provides for equity ownership opportunities to directors in
order to encourage and enable them to participate in the Company's future
prosperity and growth and to better match the interests of directors with those
of shareholders.
These objectives will be promoted through the granting to Outside Directors
(defined below) of equity-based awards ("awards"). The types of awards that may
be granted under the Plan are options ("Stock Options") to purchase Shares
(defined below) and grants of Shares or Share Units subject to Section 6
("Restricted Shares" or "Restricted Share Units").
SECTION 2 | ADMINISTRATION
The Plan shall be administered by the Human Resources and Compensation Committee
(the "Committee") of the Company's Board of Directors which shall have the power
and authority to grant Stock Options and Restricted Shares or Restricted Share
Units to members of the Board of Directors of the Company who do not serve as
employees of the Company ("Outside Directors"). In particular, the Committee
shall have the authority to: (i) select Outside Directors as recipients of
awards; (ii) determine the number and type of awards to be granted; (iii)
determine the terms and conditions, not inconsistent with the terms hereof, of
any award; (iv) adopt, alter and repeal such administrative rules, guidelines
and practices governing the Plan as it shall, from time to time, deem advisable;
(v) interpret the terms and provisions of the Plan and any award granted and any
agreements relating thereto; and (vi) take any other actions the Committee
considers appropriate in connection with, and otherwise supervise the
administration of, the Plan. All decisions made by the Committee pursuant to the
provisions hereof shall be made in the Committee's sole discretion and shall be
final and binding on all persons.
SECTION 3 | ELIGIBILITY
Only Outside Directors are eligible to receive awards under this Plan. Members
of the Committee who are Outside Directors are eligible to receive awards.
SECTION 4 | SHARES SUBJECT TO PLAN
The total number of the Company's common shares, without par value ("Shares"),
reserved and available for issuance pursuant to awards hereunder ("Available
Shares")
shall be 1.5 million. The Available Shares may consist, in whole or in part, of
authorized but unissued Shares, treasury Shares, or previously issued Shares
re-acquired by the Company, including Shares purchased on the open market.
In the event of (i) a stock dividend, stock split, reverse stock split, share
combination, or recapitalization or similar event affecting the capital
structure of the Company (each, a "Share Change"), or (ii) a merger,
consolidation, acquisition of property or shares, separation, spinoff,
reorganization, stock rights offering, liquidation, disaffiliation from the
Company of a Subsidiary or division ("Disaffiliation"), or similar event
affecting the Company or any of its subsidiaries (each, an "Organic Change"),
the Committee may in its discretion make such substitutions or adjustments as it
deems appropriate and equitable to the aggregate number of Shares reserved for
issuance under the Plan, the number and exercise price of Shares subject to
outstanding Stock Options, the purchase price, if any, for Restricted Shares or
Restricted Share Units, and the number of Shares subject to a Restricted Share
or Restricted Share Unit award. In the case of Organic Changes, such adjustments
may include, without limitation, (x) the cancellation of outstanding awards in
exchange for payments of cash, property or a combination thereof having an
aggregate value equal to the value of such awards, as determined by the
Committee in its sole discretion (it being understood that in the case of an
Organic Change with respect to which shareholders receive consideration other
than publicly traded equity securities of the ultimate surviving entity, any
such determination by the Administrator that the value of an Stock Option shall
for this purpose be deemed to equal the excess, if any, of the value of the
consideration being paid for each Share pursuant to such Organic Change over the
exercise price of such Stock Option shall conclusively be deemed valid), (y) the
substitution of other property (including, without limitation, cash or other
securities of the Company and securities of entities other than the Company) for
the Shares subject to outstanding awards, and (z) in connection with any
Disaffiliation, arranging for the assumption of awards, or replacement of awards
with new awards based on other property or other securities (including, without
limitation, other securities of the Company and securities of entities other
than the Company), by the affected subsidiary, affiliate or division or by the
entity that controls such subsidiary, affiliate or division following such
Disaffiliation (as well as any corresponding adjustments to awards that remain
based upon Company securities).
Notwithstanding the preceding paragraph, (i) any adjustments made pursuant to
such paragraph to awards that are considered "deferred compensation" within the
meaning of Section 409A ("Section 409A") of the Internal Revenue Code of 1986,
as amended (the "Code"), shall be made in compliance with the requirements of
Section 409A, (ii) any adjustments made pursuant to such paragraph to awards
that are not considered "deferred compensation" subject to Section 409A shall be
made in such a manner as to ensure that after such adjustment, the awards either
continue not to be subject to Section 409A or comply with the requirements of
Section 409A, and (iii) the Committee shall not have the authority to make any
adjustments pursuant to such paragraph to the extent that the existence of such
authority would cause an award that is not intended to be subject to Section
409A to be subject thereto.
2
SECTION 5 | STOCK OPTIONS
Any Stock Options granted under the Plan shall be in such form as the Committee
may from time to time approve and the provisions of Stock Option awards need not
be the same with respect to each optionee. Stock Options granted under the Plan
will be options that are not intended to qualify as incentive stock options
under Section 422 of the Code ("NQSOs").
Stock Options granted under the Plan shall be subject to the following terms and
conditions and shall contain such additional terms and conditions not
inconsistent with the terms of the Plan as the Committee deems appropriate.
(a) Eligibility and Grant. All Stock Options shall be evidenced by a written
agreement, which shall be dated as of the date on which a Stock Option is
granted, signed (electronically or otherwise) by an officer of the Company
authorized by the Committee, and signed (electronically or otherwise) by the
Outside Director. Such agreement shall describe the Stock Options and state that
such Stock Options are subject to all terms and provisions of the Plan.
(b) Exercise of Stock Options. Stock Options shall become exercisable at such
time or times and subject to such terms and conditions (including, without
limitation, installment or cliff exercise provisions) as shall be determined by
the Committee. The Committee shall have the authority, in its discretion, to
accelerate the time at which a Stock Option shall be exercisable whenever it may
determine that such action is appropriate by reason of changes in applicable tax
or other law or other changes in circumstances occurring after the award of such
Stock Options.
(c) Exercise Price. The exercise price per Share purchasable under a Stock
Option shall be equal to the fair market value on the day the Stock Option is
granted. Other than as a result of an adjustment pursuant to Section 4, the
exercise price of a Stock Option may not be reduced without shareholder
approval.
(d) Maximum Term. Each Stock Option shall be exercisable for ten (10) years from
the date of grant or such shorter period of time as may be provided in the Stock
Option agreement.
(e) Transferability of Stock Options. Except as otherwise provided hereunder,
Stock Options shall be transferable by the Outside Director only with prior
approval of the Committee. Any attempted transfer without Committee approval
shall be null and void. Unless Committee approval of the transfer shall have
been obtained, all Stock Options shall be exercisable during the Outside
Director's lifetime only by the Outside Director or the Outside Director's legal
representative. Without limiting the generality of the foregoing, the Committee
may, in the manner established by the Committee, provide for the irrevocable
transfer, without payment of consideration, of any Stock Option by an Outside
Director to a member of the Outside Director's family or to a family entity. In
such case, the Stock Option shall be exercisable only by such transferee. For
purposes of
3
this provision: (i) an Outside Director's "family" shall include the Outside
Director's child, stepchild, grandchild, parent, stepparent, grandparent,
spouse, former spouse, sibling, niece, nephew, mother-in-law, father-in-law,
son-in-law, daughter-in-law, brother-in-law, or sister-in-law, including through
adoptive relationships, and any person sharing the Outside Director's household
(other than a tenant or employee); and (ii) a "family entity" shall include a
trust in which the foregoing persons have more than fifty percent of the
beneficial interest, a foundation in which the foregoing persons (or the Outside
Director) control the management of assets, and any other entity in which the
foregoing persons (or the Outside Director) own more than fifty percent of the
voting interests; and (iii) neither a transfer under a domestic relations order
in settlement of marital property rights nor a transfer to an entity in which
more than fifty percent of the voting interests are owned by family members (or
the Outside Director) in exchange for an interest in that entity shall be
considered to be a transfer for consideration.
(f) Method of Exercise. Stock Options may be exercised in whole or in part by
giving written notice of exercise to the Company specifying the number of Shares
to be purchased. No Shares shall be transferred until full payment therefor has
been made. Payment for exercise of a Stock Option may be made (i) in cash, (ii)
by delivery of Shares already owned by the Outside Director, (iii) by
attestation of ownership of such already-owned Shares, (iv) by delivery of cash
on the extension of credit by a broker-dealer to whom the Outside Director has
submitted a notice of exercise or an irrevocable election to effect such
extension of credit, or (v) by any combination of the foregoing.
(g) Termination of Option. Except as otherwise provided herein, unless otherwise
determined by the Committee at or after grant or termination, if an Outside
Director ceases to be a member of the Company's Board of Directors for any
reason, then all Stock Options or any unexercised portion of such Stock Options
which otherwise are exercisable shall remain exercisable until expiration of the
original term of such Stock Options.
SECTION 6 | RESTRICTED SHARES AND RESTRICTED SHARE UNITS
Restricted Shares or Restricted Share Units may be granted to Outside Directors
alone or in addition to other awards granted under the Plan. For purposes of the
Plan, "Restricted Share Units" shall mean a grant of a right to receive Shares
in the future, with such units subject to a risk of forfeiture or other
restrictions that will lapse upon the achievement of performance or other
objectives. Any Restricted Shares or Restricted Share Units granted under the
Plan shall be subject to the following restrictions and conditions, and shall
contain such additional terms and conditions in the applicable award agreement,
not inconsistent with the terms of the Plan, as the Committee deems appropriate.
The provisions of Restricted Share or Restricted Share Unit awards need not be
the same with respect to each recipient.
(a) Restricted Share and Restricted Share Unit Award Agreement. Each Restricted
Share or Restricted Share Unit grant shall be evidenced by an agreement executed
on behalf of the Company by an officer designated by the Committee. Such
Restricted Share
4
or Restricted Share Unit Award Agreement shall describe the Restricted Shares or
Restricted Share Units and state that such Restricted Shares or Restricted Share
Units are subject to all the terms and provisions of the Plan and shall contain
such other terms and provisions, consistent with the Plan, as the Committee may
approve. At the time any Restricted Shares are awarded, the Committee may
determine that such Shares shall, after vesting, be further restricted as to
transferability or be subject to repurchase by the Company upon occurrence of
certain events determined by the Committee, in its sole discretion, and
specified in the applicable Restricted Share Award Agreement. Awards of
Restricted Shares or Restricted Share Units must be accepted by a grantee
thereof within a period of thirty (30) days (or such other period as the
Committee may specify at grant) after the award date by executing the Restricted
Share or Restricted Share Unit Award Agreement and paying the purchase price, if
any, of such award. The prospective recipient of a Restricted Share or
Restricted Share Unit award shall not have any rights with respect to such
award, unless and until such recipient has executed an agreement evidencing the
award and has delivered a fully executed copy thereof to the Company, and has
otherwise complied with the applicable terms and conditions of such award.
(b) Share Restrictions. Subject to the provisions of this Plan and the
applicable Restricted Share or Restricted Share Unit Award Agreement, during a
period set by the Committee commencing with the date of such award and ending on
such date as determined by the Committee at grant (the "Restriction Period"),
the participant shall not be permitted to sell, transfer, pledge, assign or
otherwise encumber shares of Restricted Shares or Restricted Share Units awarded
under the Plan. The Committee shall have the authority, in its absolute
discretion, to accelerate the time at which any or all of the restrictions shall
lapse with respect to any Restricted Shares or Restricted Share Units or to
remove any or all restrictions after the grant of such Restricted Shares. Unless
otherwise determined by the Committee at or after grant or termination of
service, if a participant's service to the Company terminates during the
Restriction Period, all Restricted Shares or Restricted Share Units held by such
participant still subject to restriction shall be forfeited by the participant.
(c) Stock Certificate and Legends. Each participant receiving a Restricted Share
award shall be issued a stock certificate or book-entry account on the Company's
transfer agent's records in respect of such Restricted Shares. Such certificate
or book entry shall be registered in the name of the participant. The Committee
may require that any stock certificates evidencing such Shares be held in
custody by the Company until the restrictions thereon shall have lapsed, and
that, as a condition of any Restricted Shares award, the participant shall have
delivered a stock power, endorsed in blank, relating to the Shares covered by
such award.
(d) Shareholder Rights. Except as provided in this Section 6, the recipient
shall have, with respect to the Restricted Shares covered by any award, all of
the rights of a shareholder of the Company, including the right to vote the
Shares, and the right to receive any dividends or other distributions, with
respect to the Shares, but subject, however, to those restrictions placed on
such Shares pursuant to this Plan and as specified by the Committee in the
Restricted Share Award Agreement. A participant shall not have
5
any rights as a shareholder of the Company with respect to the Restricted Share
Units unless and until the Shares underlying such Restricted Share Units have
been issued and registered in the name of such participant; provided that a
Restricted Share Unit Award Agreement may provide for dividend equivalents to be
paid with respect to outstanding Restricted Share Units.
(e) Expiration of Restriction Period. If and when the Restriction Period expires
without a prior forfeiture of the Restricted Shares subject to such Restriction
Period, unrestricted certificates for such shares shall be delivered to the
participant. Unrestricted shares subject to vested Restricted Share Units shall
be delivered to the participant pursuant to the terms of the applicable
Restricted Share Unit Award Agreement (which may, subject to Section 10(h),
provide for deferral of such delivery to a date that is later than the date of
vesting).
SECTION 7 | CHANGE OF CONTROL
(a) In the event of a Change of Control (as defined below), unless otherwise
determined by the Committee at the time of grant and subject to Section 7(c),
the following provisions shall apply:
(i) On the date that such Change of Control occurs, any or all Stock
Options not previously exercisable and vested shall become fully
exercisable and vested, and all outstanding Stock Options shall remain
exercisable for the remainder of their original term.
(ii) On the date that such Change of Control occurs, the restrictions
applicable to any or all Restricted Shares and Restricted Share Units shall
lapse and such awards shall be fully vested.
(b) For purposes of this Plan, "Change of Control" means any of the following:
(i) the acquisition by any individual, entity or group (within the meaning
of Section 13(d)(3) or 14(d)(2) of the Exchange Act) (a "Person") of
beneficial ownership (within the meaning of Rule 13d-3 promulgated under
the Securities Exchange Act of 1934, as amended (the "Exchange Act")) of
twenty-five percent (25%) or more of either (x) the then outstanding Shares
of the Company (the "Outstanding Company Common Shares"), or (y) the
combined voting power of the then outstanding voting securities of the
Company entitled to vote generally in the election of directors (the
"Outstanding Company Voting Securities"); provided, however, that for
purposes of this subsection (i), the following acquisitions shall not
constitute a Change of Control: (A) any acquisition directly from the
Company or any corporation controlled by the Company, (B) any acquisition
by the Company or any corporation controlled by the Company, (C) any
acquisition by any employee benefit plan (or related trust) sponsored or
maintained by the Company or any corporation controlled by the Company, or
(D)
6
any acquisition by any corporation that is a Non-Control Acquisition (as
defined in subsection (iii) of this Section 7(b)); or
(ii) individuals who, as of the effective date of this Plan, constitute the
Board of Directors of the Company (the "Incumbent Board") cease for any
reason to constitute at least a majority of the Board of Directors of the
Company; provided, however, that any individual becoming a director
subsequent to the effective date whose election, or nomination for election
by the Company's shareholders, was approved by a vote of at least a
majority of the directors then comprising the Incumbent Board shall be
considered as though such individual were a member of the Incumbent Board,
but excluding, for this purpose, any such individual whose initial
assumption of office occurs as a result of an actual or threatened election
contest with respect to the election or removal of directors or other
actual or threatened solicitation of proxies or consents by or on behalf of
a Person other than the Board of Directors of the Company; or
(iii) consummation of a reorganization, merger or consolidation or sale or
other disposition of all or substantially all of the assets of the Company
or the acquisition by the Company of assets or shares of another
corporation (a "Business Combination"), unless such Business Combination is
a Non-Control Acquisition. A "Non-Control Acquisition" shall mean a
Business Combination where: (x) all or substantially all of the individuals
and entities who were the beneficial owners, respectively, of the
Outstanding Company Common Shares and Outstanding Company Voting Securities
immediately prior to such Business Combination beneficially own, directly
or indirectly, more than fifty percent (50%) of, respectively, the then
outstanding shares of common stock and the combined voting power of the
then outstanding voting securities entitled to vote generally in the
election of directors, as the case may be, of the corporation resulting
from such Business Combination (including, without limitation, a
corporation which as a result of such transaction owns the Company or all
or substantially all of the Company's assets either directly or through one
or more subsidiaries) in substantially the same proportions as their
ownership immediately prior to such Business Combination of the Outstanding
Company Common Shares and Outstanding Company Voting Securities, as the
case may be, (y) no Person (excluding any employee benefit plan (or related
trust) of the Company or such corporation resulting from such Business
Combination) beneficially owns, directly or indirectly, twenty-five percent
(25%) or more of, respectively, the then outstanding shares of common stock
of the corporation resulting from such Business Combination or the combined
voting power of the then outstanding voting securities of such corporation
except to the extent that such ownership existed prior to the Business
Combination (including any ownership that existed in the Company or the
company being acquired, if any), and (z) at least a majority of the members
of the board of directors of the corporation resulting from such Business
Combination were members of the Incumbent Board at the time of the
execution of the initial agreement, or of the action of the Board of
Directors of the Company, providing for such Business Combination; or
7
(iv) approval by the shareholders of the Company of a complete liquidation
or dissolution of the Company.
(c) Notwithstanding Section 7(a), if any Award is subject to Section 409A,
Section 7(a) shall be applicable only to the extent specifically provided in the
applicable award agreement and permitted pursuant to Section 10(h) of the Plan.
SECTION 8 | AMENDMENTS AND TERMINATION
(a) The Board may amend, alter or discontinue the Plan; provided, however, no
amendment, alteration or discontinuation shall be made (i) which would impair
the rights of an optionee, participant or permitted transferee under any award
theretofore granted, without the optionee's, participant's or transferee's
consent, except for amendments made to cause the Plan or such award to comply
with applicable law, stock exchange rules or accounting rules; or (ii) without
the approval of the Company's shareholders to the extent such approval is
required by applicable law, regulation or stock exchange rule.
Subject to the above provisions, the Company's Board of Directors shall have
authority to amend the Plan to take into account changes in applicable tax and
securities laws and accounting rules, as well as other developments.
SECTION 9 | UNFUNDED STATUS OF PLAN
The Plan is intended to constitute an "unfunded" plan for incentive and deferred
compensation. With respect to any payments or deliveries of Shares not yet made
by the Company to a participant, optionee or transferee, nothing contained
herein shall give any such participant, optionee or transferee any rights that
are greater than those of a general creditor of the Company. The Committee may
authorize the creation of trusts or other arrangements to meet the obligations
created under the Plan to deliver Shares or payments hereunder consistent with
the foregoing.
SECTION 10 | GENERAL PROVISIONS
(a) Share Transfer and Distribution. The Committee may require each person
purchasing Shares pursuant to a Stock Option or Restricted Share or Restricted
Share Unit award under the Plan to represent to and agree with the Company, in
writing, that such person is acquiring the Shares without a view to the
distribution thereof. Any certificates for such Shares may include any legend
which the Committee deems appropriate to reflect any restrictions on transfer.
All Shares or other securities delivered under the Plan shall be subject to such
stop-transfer orders and other restrictions as the Committee may deem advisable
under the rules, regulations and other requirements of the Securities and
Exchange Commission, any stock exchange upon which the Shares are then listed
and any applicable federal or state securities law, and the Committee may cause
a legend or legends to be put on any certificates evidencing such Shares to make
appropriate reference to such restrictions.
8
The Company shall not be required to deliver any Shares or other securities
under the Plan prior to such registration or other qualification of such Shares
or other securities under any state or federal law, rule or regulation as the
Committee shall determine to be necessary or advisable.
(b) Additional Arrangements. Nothing contained in this Plan shall prevent the
Company from adopting other or additional compensation arrangements for its
employees, consultants or Outside Directors.
(c) No Right to Award or Retention as Director. No person shall have any claim
or right to be granted an award under this Plan and the grant of an award shall
not confer upon any participant any right to be retained as a director of the
Company, nor shall it interfere in any way with the right of the Company to
terminate the service as a director of any of the Plan's participants at any
time.
(d) Tax Withholding. The Company shall have the right to require the grantee of
Restricted Shares or Restricted Share Units, or other person receiving such
Shares, to pay the Company the amount of any taxes which the Company is required
to withhold with respect to such Shares or, in lieu thereof, to retain, or sell
without notice, a sufficient number of Shares held by it to cover the amount
required to be withheld. The Company shall have the right to deduct from all
dividends or dividend equivalents, as the case may be, paid with respect to
Restricted Shares and Restricted Share Units the amount of any taxes which the
Company is required to withhold with respect to such dividend or dividend
equivalent payments, as the case may be.
The Company shall also have the right to require an optionee to pay to the
Company the amount of any taxes which the Company is required to withhold with
respect to the receipt by the optionee of Shares pursuant to the exercise of a
Stock Option, or, in lieu thereof, to retain, or sell without notice, a number
of Shares sufficient to cover the amount required to be withheld.
In the case of any amounts withheld for taxes pursuant to this provision in the
form of Shares, the amount withheld shall not exceed the minimum required by
applicable law and regulations.
(e) Beneficiaries. The Committee may establish such procedures as it deems
appropriate for a participant to designate a beneficiary to whom any amounts or
benefits payable in the event of the participant's death are to be paid.
(f) Laws Governing. The Plan and all awards made and action taken thereunder
shall be governed by and construed in accordance with the laws of the State of
Ohio, except to the extent superseded by federal law.
(g) Government Regulation. Notwithstanding any provisions of the Plan or any
agreement made pursuant to the Plan, the Company's obligations under the Plan
and such
9
agreement shall be subject to all applicable laws, rules and regulations and to
such approvals as may be required by any governmental or regulatory agencies.
(h) Section 409A. It is the intention of the Company that no award shall be
"deferred compensation" subject to Section 409A, unless and to the extent that
the Committee specifically determines otherwise, and the Plan and the terms and
conditions of all awards shall be interpreted accordingly. The terms and
conditions governing any awards that the Committee determines will be subject to
Section 409A of the Code, including any rules for elective or mandatory deferral
of the delivery of cash or Shares pursuant thereto, shall be set forth in the
applicable award agreement, and shall comply in all respects with Section 409A.
SECTION 11 | TERM OF PLAN
No award shall be granted pursuant to the Plan on or after May 10, 2010, but
awards granted prior to such date may extend beyond that date.
SECTION 12 | INDEMNIFICATION
No member of the Board or the Committee shall be liable for any action or
determination made in good faith with respect to the Plan or any award granted
under the Plan. Each person who is or shall have been a member of the Committee
or of the Board shall be indemnified and held harmless by the Company against
and from any loss, cost, liability or expense that may be imposed upon or
reasonably incurred by him or her in connection with or resulting from any
claim, action, suit or proceeding to which he may be a party or in which he may
be involved by reason of any action taken or failure to act under or in
connection with this Plan or any award granted under this Plan and against and
from any and all amounts paid by him or her in settlement thereof, with the
Company's approval, or paid by him or her, except a judgment based upon a
finding of bad faith, provided he or she shall give the Company an opportunity,
at its own expense, to handle and defend the same before he or she undertakes to
handle and defend it on his or her own behalf. The foregoing right of
indemnification shall not be exclusive of any other rights of indemnification to
which such person may be entitled under the Company's Articles of Incorporation
or Code of Regulations, contained in any indemnification agreements, as a matter
of law, or otherwise, or any power that the Company may have to indemnify him or
her or hold him or her harmless.
SECTION 13 | SAVINGS CLAUSE
In case any one or more of the provisions of this Plan shall be held invalid,
illegal or unenforceable in any respect, the validity, legality and
enforceability of the remaining provisions shall not in any way be affected or
impaired thereby and the invalid, illegal or unenforceable provision shall be
deemed null and void; however, to the extent permissible by law, any provision
which could be deemed null and void shall first be construed, interpreted or
revised retroactively to permit this Plan to be construed so as to foster the
intent of this Plan.
10
SECTION 14 | AWARDS TO PARTICIPANTS OUTSIDE OF UNITED STATES
The Committee may modify the terms of any award under the Plan granted to a
participant who, at the time of grant or during the term of the award, is
resident or employed outside of the United States in any manner deemed by the
Committee to be necessary or appropriate in order to accommodate differences in
local law, regulation, tax policy or custom, or so that the value and other
benefits of the award to the participant, as affected by foreign tax laws and
other restrictions applicable as a result of the participant's residence or
employment abroad, will be comparable to the value of such an award to a
participant who is resident or employed in the United States. Moreover, the
Committee may approve such supplements to, or amendments, restatements or
alternative versions of, this Plan as it may consider necessary or appropriate
for such purposes without thereby affecting the terms of this Plan as in effect
for any other purpose; provided that no such supplements, amendments,
restatements or alternative versions shall include any provisions that are
inconsistent with the terms of this Plan, as then in effect, unless this Plan
could have been amended to eliminate such inconsistency without further approval
of the shareholders of the Company.
11
Exhibit 10.27
CARDINAL HEALTH, INC.
GLOBAL EMPLOYEE STOCK PURCHASE PLAN
SECTION 1 - PURPOSE
The Cardinal Health, Inc. Employee Stock Purchase Plan is adopted and
established by Cardinal Health, Inc., an Ohio corporation, on the date set forth
below, effective as of July 1, 2000, for the general benefit of the Employees of
the Company and of certain of its Subsidiaries. The purpose of the Plan is to
facilitate the purchase of Shares by Eligible Employees.
SECTION 2 - DEFINITIONS
a. "ACT" shall mean the Securities Act of 1933, as amended.
b. "ADMINISTRATOR" shall mean the Board of Directors of the Company, a
designated committee thereof, or the person(s) or entity delegated the
responsibility of administering the Plan, which initially shall be the
Cardinal Health, Inc. Profit Sharing and Retirement Savings Plan Committee.
c. "AGENT" shall mean the bank, brokerage firm, financial institution, or
other entity or person(s) engaged, retained or appointed to act as the
agent of the Employer and of the Participants under the Plan, which
initially shall be Merrill Lynch, Pierce, Fenner, & Smith, Inc.
d. "BOARD" shall mean the Board of Directors of the Company.
e. "CLOSING VALUE" shall mean, as of a particular date, the value of a Share
determined by the closing sales price for such Share (or the closing bid,
if no sales were reported) as quoted on The New York Stock Exchange for the
last market trading day prior to the date of determination, as reported in
The Wall Street Journal or such other source as the Administrator deems
reliable.
f. "CODE" shall mean the Internal Revenue Code of 1986, as amended and
currently in effect, or any successor body of federal tax law.
g. "COMPANY" shall mean Cardinal Health, Inc., including any successor
thereto.
h. "COMPENSATION", unless otherwise required by local law, shall mean wages,
salaries, fees for professional services and other amounts received for
personal services actually rendered in the course of employment with the
Employer (including, but not limited to, commissions paid to salesmen,
compensation for services on the basis of a percentage of profits,
commissions on insurance premiums, tips and bonuses) including amounts
excludible from the Employee's gross income under Code Section 402(a)(8)
(relating to a Code Section 401(k) arrangement), Code Section 402(h)
(relating to a Simplified Employee Pension), Code Section 125 (relating to
a cafeteria plan) or Code Section 403(b) (relating to a tax-sheltered
annuity) and compensation paid by the Employer to an Employee through
another person under the common paymaster provisions of Code Sections
3121(s) and 3306(p) or under applicable savings or pension plans of
Employer of the Employee. Compensation does not include, unless otherwise
required by local law: (1) amounts realized from the exercise or sale of a
non-qualified stock option, or (2) amounts realized when restricted stock
(or property) held by an Employee either becomes freely transferable or is
no longer subject to a substantial risk of forfeiture or becomes fully
owned by the Employee, or (3) amounts realized from the exercise, sale,
exchange, or other disposition of stock acquired under a qualified or
incentive stock option, (4) moving allowances, automobile allowances,
tuition reimbursement, financial/tax planning reimbursement, lunch
vouchers, house allowances, and other allowances that receive special tax
benefits,
Page 1
other extraordinary compensation, including tax "gross-up" payments, and
imputed income from other employer-provided benefits, and (5) other amounts
that receive special tax benefits, such as premiums for group term life
insurance or contributions made by the Employer (whether or not under
salary reduction agreement) or mandatory payments made by the Employer to
the Employee under the applicable law of the jurisdiction in which the
Employer of this Employee is located or the Employee is employed or
resides.
i. "DESIGNATED SUBSIDIARIES" shall mean all Subsidiaries whose Employees have
been designated by the Administrator, in its sole discretion, as eligible
to participate in the Plan.
j. "ELIGIBLE EMPLOYEE" shall mean an Employee of the Designated Subsidiary who
is designated to participate in the Plan at the sole discretion of the
Designated Subsidiary; provided, however, that such discretion shall not be
exercised in violation of the applicable labor or other laws relating to
discrimination based on gender, race, disability, age, national or social
origin, political opinion, union membership or religious belief, or
collective bargaining or other negotiated agreements.
k. "EMPLOYEE" shall mean individual who is a regular full time or part time
Employee of the Employer for at least 30 days. An Employee may work either
full time or part time work schedule and is normally included in the
authorized staffing target and budget. Employee also includes the Employee
who has been hired on a temporary contract but who is expected to fill a
permanent staffing need and who is classified as a "PRN" or "on-call
Employee". The Employee shall not include unionized Employee as defined by
the regular practices of the Employer participating in the Plan to the
extent permissible under local law.
l. "EMPLOYER" means, individually and collectively, the Company and the
Designated Subsidiaries.
m. "ENROLLMENT PERIOD" shall mean the period immediately preceding the
Offering Period that is designated by the Administrator in its discretion
as the period during which an Eligible Employee may elect to participate in
the Plan.
n. "OFFERING PERIOD" shall mean the period during which Participants in the
Plan authorize payroll deductions or provide alternative contributions to
fund the purchase of Shares on their behalf under the Plan pursuant to the
options granted to them hereunder or the period during which participants
in the Plan provide alternative contributions. Alternative contributions
for the purpose of this Plan shall mean payment of contributions through
personal checks of the Participants or such other means of contributing to
the Plan as authorized by the Administrator.
o. "PARTICIPANT" shall mean any Eligible Employee who has elected to
participate in the Plan for an Offering Period by authorizing payroll
deductions or by making alternative contributions and following all
applicable procedures established by the Administrator during the
Enrollment Period for such Offering Period.
p. "PLAN" shall mean this Cardinal Health, Inc. Global Employee Stock Purchase
Plan as amended from time to time.
q. "PLAN ACCOUNT" shall mean the individual account established for each
Participant for purposes of accounting for and/or holding each
Participant's payroll deductions, alternative contributions, Shares, etc.
r. "PLAN YEAR" shall mean the fiscal year of the Company.
s. "PURCHASE PRICE" shall mean, for each Share purchased in accordance with
Section 4 hereof, an amount equal to the lesser of (1) eighty-five percent
(85%) of the Closing Value of a Share on the first Trading Day of each
Offering Period (which for Plan purposes shall be deemed to be the date the
option to purchase such Shares was granted to each Eligible Employee who
is, or elects to become, a Participant); or (2) eighty-five percent (85%)
of the Closing Value of such Share on the last Trading Day of the Offering
Period (which for Plan purposes shall be deemed to be the date each such
option to purchase such Shares was exercised).
Page 2
t. "SHARES" means the Class A common shares, without par value, of the
Company.
u. "SUBSIDIARY" shall mean a corporation or other entity, domestic or foreign,
of which not less than fifty percent (50%) of the voting shares are held by
the Company or a Subsidiary (except for the U.K. in which this term shall
mean a corporation or other entity, domestic or foreign, of which more than
fifty percent (50%) ownership of the voting shares are held by the Company
or a Subsidiary) whether or not such corporation or other entity now exists
or is hereafter organized or acquired by the Company or a Subsidiary (or as
otherwise may be defined in Code Section 424).
v. "TRADING DAY" shall mean a day on which The New York Stock Exchange is open
for trading.
SECTION 3 - ELIGIBLE EMPLOYEES
a. In General. Participation in the Plan is voluntary. All Eligible
Employees of an Employer are eligible to participate in the Plan. All Eligible
Employees granted options to purchase Shares hereunder shall have the same
rights and privileges as every other such Eligible Employee, and only Eligible
Employees of an Employer satisfying the applicable requirements of the Plan will
be entitled to be granted options hereunder.
b. Limitations on Rights. An Employee who otherwise is an Eligible
Employee shall not be entitled to purchase Shares under the Plan if such
purchase would cause such Eligible Employee to own Shares (including any Shares
which would be owned if such Eligible Employee purchased all of the Shares made
available for purchase by such Eligible Employee under all options or rights
then held by such Eligible Employee, whether or not then exercisable)
representing five percent (5%) or more of the total combined voting power or
value of all classes of stock of the Company or any Subsidiary.
SECTION 4 - ENROLLMENT AND OFFERING PERIODS
a. Enrolling in the Plan. To participate in the Plan, an Eligible
Employee must enroll in the Plan. Enrollment for a given Offering Period will
take place during the Enrollment Period for such Offering Period. The
Administrator shall designate the initial Enrollment Period and each subsequent
Enrollment Period and the Offering Period to which each Enrollment Period
relates. Participation in the Plan with respect to any one or more of the
Offering Periods shall neither limit nor require participation in the Plan for
any other Offering Period.
b. The Offering Period. Any Employee who is an Eligible Employee and
who desires to be granted options to purchase Shares hereunder must enroll in
accordance with the procedures established by the Administrator during an
Enrollment Period. Such authorization shall be effective for the Offering Period
immediately following such Enrollment Period. The duration of an Offering Period
shall be determined by the Administrator prior to the Enrollment Period and
shall commence on the first day (or the first Trading Day) of the Offering
Period and end on the last day (or the last Trading Day) of the Offering Period;
provided, however, that if the Administrator terminates the Plan during an
Offering Period, pursuant to its authority in Section 17 of the Plan, such
Offering Period shall be deemed to end on the date the Plan is terminated. The
termination of the Plan and the Offering Period shall end the Participant's
rights to contribute amounts to the Plan or continue participation in the
Offering Period. The date of termination of the Plan shall be deemed to be the
final day of the Offering Period for purposes of determining the Purchase Price
under the Offering Period and all amounts contributed during the Offering Period
will be used as of such termination date to purchase Shares in accordance with
the provisions of Section 9 of this Plan.
The Administrator may designate one or more Offering Periods during
each Plan Year during the term of this Plan. On the first day (or the First
Trading Day) of each Offering Period, each Participant shall be granted an
option to purchase Shares under the Plan. Each option granted hereunder shall
expire at the end of the Offering Period for which it was granted. In no event
may an option granted hereunder be exercised after the expiration of 27 months
from the date of grant.
Page 3
c. Changing Enrollment. The offering of Shares pursuant to options
granted under the Plan shall occur only during an Offering Period and shall be
made only to Participants. Once an Eligible Employee is enrolled in the Plan,
the Administrator or Employer will inform the Agent of such fact. Once enrolled,
a Participant shall continue to participate in the Plan for each successive
Offering Period (s) until he or she terminates his or her participation by
revoking his or her payroll deduction authorization or by revoking his or her
alternative contribution authorization or not contributing his or her
alternative contributions or ceases to be an Eligible Employee. Once a
Participant has elected to participate under the Plan, that Participant's
payroll deduction authorization or alternative contribution authorization shall
apply to all subsequent Offering Periods unless and until the Participant ceases
to be an Eligible Employee, or modifies or terminates said authorization. If a
Participant desires to change his or her rate of contribution, he or she may do
so effective for the next Offering Period by following the procedures
established by the Administrator during the Enrollment Period immediately
preceding such Offering Period.
SECTION 5 - TERM OF PLAN
This Plan shall be in effect from July 1, 2000, until it is terminated
by action of the Board.
SECTION 6 - NUMBER OF SHARES TO BE MADE AVAILABLE
Subject to adjustment as provided in Section 16 hereof, the total
number of Shares made available for purchase by Participants granted options
which are exercised under Section 9 hereof is 3 million, which may consist of
authorized but unissued shares, treasury shares, or shares purchased by the Plan
in the open market. The provisions of Section 9 b. shall control in the event
the number of Shares covered by options which are exercised for any Offering
Period exceeds the number of Shares available for sale under the Plan. If all of
the Shares authorized for sale under the Plan have been sold, the Plan shall
either be continued through additional authorizations of Shares made by the
Board (such authorizations must, however, comply with Section 17 hereof), or
shall be terminated in accordance with Section 17 hereof.
SECTION 7 - USE OF FUNDS
All payroll deductions or alternative contributions received or held
by an Employer under the Plan will be used to purchase Shares in accordance with
the provisions of this Plan. Any amounts held by an Employer or other party
holding amounts in connection with or as a result of payroll withholding or
alternative contribution made pursuant to the Plan and pending the purchase of
Shares hereunder shall be considered a non-interest-bearing, unsecured
indebtedness extended to the Employer or other party by the Participants, unless
otherwise required under applicable local law or securities regulatory body
requirements of the country in which the Employer of the Employee is located or
the Employee is employed or resides, as the case may be. Administrative expenses
of the Plan shall be allocated to each Participant's Plan Account unless such
expenses are paid by the Employer.
SECTION 8 - AMOUNT OF CONTRIBUTION; METHOD OF PAYMENT
a. Payroll Withholding or Payroll Deduction or Alternative
Contributions. Except as otherwise specifically provided herein, the Purchase
Price will be payable by each Participant by means of payroll withholding. The
withholding or alternative contributions shall be in increments of one percent
(1%). Unless otherwise authorized by the Administrator, the minimum withholding
or alternative contributions permitted shall be an amount equal to one percent
(1%) of a Participant's Compensation and the maximum withholding or alternative
contributions shall be an amount equal to fifteen percent (15%) of a
Participant's Compensation. In any event, the total withholding or alternative
contributions permitted to be made by any Participant for a calendar year shall
be limited to the sum of legal currency equivalent of U.S. $21,250. The actual
percentage of Compensation to be deducted or contributed shall be specified by a
Participant in his or her authorization to participate in the Plan. Unless
otherwise authorized by the Administrator, Participants may not deposit any
separate cash payments into their Plan Accounts.
b. Application of Withholding Rules. Payroll withholding will commence
with the first payroll issued during the Offering Period and will, except as
otherwise provided herein, continue with each payroll
Page 4
throughout the entire Offering Period, except for pay periods for which such
Participant receives no compensation (e.g., uncompensated personal leave, leave
of absence). A pay period which ends at such time that it is administratively
impracticable to credit any payroll for such pay period to the then-current
Offering Period will be credited in its entirety to the immediately subsequent
Offering Period. A pay period which overlaps Offering Periods will be credited
in its entirety to the Offering Period in which it is paid. Alternative
contributions will be made in accordance with the procedure established by the
Administrator. Payroll withholding or alternative contributions shall be
retained by the Employer or other party, designated by the Administrator or the
Employer as the case may be, until applied to the purchase of Shares as
described in Section 9 hereof and the satisfaction of any related federal,
state, local or other tax withholding obligations (including any employment tax
obligations).
At the time the Shares are purchased, or at the time some or all of
the Shares issued under the Plan are disposed of, Participants must make
adequate provision for the Employer's federal, state, local or other tax
withholding obligations (including employment taxes), if any, which arise upon
the purchase or disposition of the Shares. At any time, the Employer may
withhold from each Participant's Compensation the amount necessary for the
Employer to meet applicable withholding obligations, including any withholding
required to make available to the Employer any tax deductions or benefits
attributable to the sale or early disposition of Shares by the Participant. Each
Participant, as a condition of participating under the Plan, agrees to bear
responsibility for all federal, state, local and other income taxes required to
be withheld from his or her Compensation as well as the Participant's portion of
FICA (both the OASDI and Medicare components), and other applicable social
security or similar such taxes, with respect to any Compensation arising on
account of the purchase or disposition of Shares. The Employer may increase
income and/or employment tax withholding on a Participant's Compensation after
the purchase or disposition of Shares in order to comply with federal, state,
local and other tax laws, and each Participant agrees to sign any and all
appropriate documents to facilitate such withholding.
SECTION 9 - PURCHASING, TRANSFERRING SHARES
a. Maintenance of Plan Account. Upon the exercise of a Participant's
initial option to purchase Shares under the Plan, the Agent shall establish a
Plan Account in the name of such Participant. At the close of each Offering
Period, the aggregate amount deducted during such Offering Period by the
Employer from a Participant's Compensation, or alternative contributions made to
the Plan by the Participant (and credited to an account maintained by the
Employer or other party for bookkeeping purposes) will be communicated by the
Employer to the Agent and shall thereupon be credited by the Agent to such
Participant's Plan Account (unless the Participant has given notice to the
Administrator of his or her revocation of authorization prior to the date such
communication is made). As of the last day of each Offering Period, or as soon
thereafter as is administratively practicable, each Participant's option to
purchase Shares will be exercised automatically for him or her by the Agent with
respect to those amounts reported to the Agent by the Administrator or Employer
as creditable to that Participant's Plan Account. On the date of exercise, the
amount then credited to the Participant's Plan Account for the purpose of
purchasing Shares hereunder will be divided by the Purchase Price and there
shall be transferred to the Participant's Plan Account by the Agent the number
of whole and/or fractional shares which results, as permitted by local law.
The Agent shall hold in its name, or in the name of its nominee, all
Shares so purchased and allocated. No certificate will be issued to a
Participant for Shares held in his or her Plan Account unless he or she so
requests in writing or unless such Participant's active participation in the
Plan is terminated due to death, disability, separation from service or
retirement. Participation in the Plan, purchase, ownership and sale of Shares
under the Plan, is subject to risk of fluctuation in Shares' price and currency
exchange.
b. Insufficient Number of Available Shares. In the event the number of
Shares covered by options which are exercised for any Offering Period exceeds
the number of Shares available for sale under the Plan, the number of Shares
actually available for sale hereunder shall be limited to the remaining number
of Shares authorized for sale under the Plan and shall be allocated by the Agent
among the Participants in proportion to each Participant's Compensation during
the Offering Period over the total Compensation of all Participants during the
Offering Period. Any excess amounts withheld and credited to Participants' Plan
Accounts then shall be returned to the Participants as soon as is
administratively practicable.
Page 5
c. Handling Excess Shares. In the event that the number of Shares
which would be credited to any Participant's Plan Account in any Offering Period
exceeds the limit specified in Section 3 b. hereof, such Participant's Plan
Account shall be credited with the maximum number of Shares permissible, and the
remaining amounts will be refunded in cash as soon as administratively
practicable.
d. Status Reports. Statements of each Participant's Plan Account shall
be given to Participants at least annually.
SECTION 10 - DIVIDENDS AND OTHER DISTRIBUTIONS
a. Reinvestment of Dividends. Subject to applicable law, cash
dividends and other cash distributions received by the Agent on Shares held in
its custody hereunder will be credited to the Plan Accounts of individual
Participants in accordance with such Participants' interests in the Shares with
respect to which such dividends or distributions are paid or made, and will be
applied, as soon as practical after the receipt thereof by the Agent, to the
purchase in the open market at prevailing market prices of the number of whole
Shares capable of being purchased with such funds (after deduction of any bank
service fees, brokerage charges, transfer taxes, and any other transaction fee,
expense or cost payable in connection with the purchase of such Shares and not
otherwise paid by the Employer and subject to the Company's obligation to
withhold federal, state, or other local taxes).
b. Shares to Be Held in Agent's Name. All purchases of Shares made
pursuant to this Section will be made in the name of the Agent or its nominee,
shall be held as provided in Section 9 hereof, and shall be transferred and
credited to the Plan Account(s) of the individual Participant(s) to which such
dividends or other distributions were credited. Dividends paid in the form of
Shares will be allocated by the Agent, as and when received, with respect to
Shares held in its custody hereunder to the Plan Accounts of individual
Participants in accordance with such Participants' interests in such Shares with
respect to which such dividends were paid. Property, other than Shares or cash,
received by the Agent as a distribution on Shares held in its custody hereunder,
shall be sold by the Agent for the accounts of the Participants, and the Agent
shall treat the proceeds of such sale in the same manner as cash dividends
received by the Agent on Shares held in its custody hereunder.
c. Tax Responsibilities. The automatic reinvestment of dividends under
the Plan will not relieve a Participant (or Eligible Employee with a Plan
Account) of any income or other tax that may be due on or with respect to such
dividends. The Agent shall report to each Participant (or Eligible Employee with
a Plan Account) the amount of dividends credited to his or her Plan Account.
SECTION 11 - VOTING OF SHARES
A Participant shall have no interest or voting right in the Shares
covered by his or her option until such option has been exercised. Shares held
for a Participant (or Eligible Employee with a Plan Account) in his or her Plan
Account will be voted in accordance with the Participant's (or Eligible
Employee's) express directions. In the absence of any such directions, such
Shares will not be voted.
SECTION 12 - IN-SERVICE DISTRIBUTION OR SALE OF SHARES
a. Sale of Shares. Subject to the provisions of Section 19 hereof, a
Participant may at any time, and without withdrawing from the Plan, by giving
notice to the Agent, direct the Agent to sell all or part of the Shares held on
behalf of the Participant. Upon receipt of such a notice, the Agent shall, as
soon as practicable after receipt of such notice, sell such Shares in the
marketplace at the prevailing market price and transmit the net proceeds of such
sale (less any bank service fees, brokerage charges, transfer taxes, and any
other transaction fee, expense or cost) to the Participant.
b. In-Service Share Distributions. A Participant may, without
withdrawing from the Plan, request that a certificate for all or part of the
whole number of Shares held in his or her Plan Account be sent to him or her
after the relevant Shares have been purchased and allocated subject to the
requirement that such Shares be held in the Participant's Plan Account for a
period of at least 24 months after the date of exercise, as described in
Page 6
Section 9 a., above. All such requests must be submitted in writing to the
Agent. No certificate for a fractional Share will be issued; the fair value of
fractional Shares on the date of withdrawal of all Shares credited to a
Participant's Plan Account shall be paid in cash to such Participant. The Plan
may impose a reasonable charge, to be paid by the Participant, for each stock
certificate so issued prior to the date active participation in the Plan ceases;
such charge shall be paid by the Participant to the Administrator or Employer
prior to the date any distribution of a certificate evidencing ownership of such
Shares occurs.
SECTION 13 - CESSATION OF ACTIVE PARTICIPATION
A Participant may at any time, by giving notice to the Administrator
or Employer, revoke his or her authorization for payroll deduction or
alternative contributions for the Offering Period in which such revocation is
made. A Participant who revokes authorization or does not make alternative
contributions for payroll deduction may not again participate under the Plan
until the next Offering Period immediately subsequent to the Offering Period
during which the Participant revoked payroll deduction authorization or did not
make alternative contributions with respect thereto.
SECTION 14 - SEPARATION FROM EMPLOYMENT
Separation from employment for any reason, including death,
disability, termination or retirement shall be deemed to be a cessation of
active participation in the Plan as described under Section 13 hereof.
SECTION 15 - ASSIGNMENT
Neither payroll deductions nor alternative contributions credited to a
Participant's Plan Account nor any rights to purchase Shares under the Plan may
be assigned, alienated, transferred, pledged, or otherwise disposed of in any
way by a Participant other than by will or the laws of descent and distribution.
Any such assignment, alienation, transfer, pledge, or other disposition shall be
without effect, except that the Administrator may treat such act as an election
to withdraw from the Plan. A Participant's right to purchase Shares under this
Plan may be exercisable during the Participant's lifetime only by the
Participant. A Participant's Plan Account shall be payable to the Participant's
estate upon his or her death.
SECTION 16 - ADJUSTMENT OF AND CHANGES IN SHARES
If at any time after the effective date of the Plan the Company shall
subdivide or reclassify the Shares which have been or may be optioned under the
Plan, or shall declare thereon any stock split or dividend payable in Shares, or
shall alter the capital structure of the Shares or the Company in any similar
manner, then the number and class of shares held in the Plan and which may
thereafter be optioned (in the aggregate and to any Participant) shall be
adjusted accordingly, and in the case of each option outstanding at the time of
any such action, the number and class of shares which may thereafter be
purchased pursuant to such option and the Purchase Price shall be adjusted
accordingly, as necessary to preserve the rights of the holder(s) of such Shares
and option(s).
SECTION 17 - AMENDMENT OR TERMINATION OF THE PLAN
The Board shall have the right, at any time, to amend, modify or
terminate the Plan without notice; provided, however, that no Participant's
existing options shall be adversely affected by any such amendment, modification
or termination, except to comply with applicable law, stock exchange rules or
accounting rules. Notwithstanding the foregoing, the Board shall have the right
to terminate the Plan with respect to all future payroll deductions and related
purchases at any time. Such termination of the Plan shall also terminate any
current Offering Period in accordance with Section 4 of the Plan.
Designations of participating corporations may be made from time to
time from among a group of corporations consisting of the Employer, its parent
and its Subsidiaries (including corporations that become Subsidiaries or a
parent after the adoption and approval of the Plan).
Page 7
The Company may amend or modify the Plan or make regulations for the
operation of the Plan that are not inconsistent with these rules to apply to
Employees and Participants who are employed or resident outside of the United
States of America in accordance with the relevant law. "Relevant law" shall mean
the applicable law of the jurisdiction in which the Employer of the Employee is
located or where the Employee is employed or resides and the securities
regulatory body requirements and the taxation requirements of that same
jurisdiction.
SECTION 18 - ADMINISTRATION
a. Administration. The Plan shall be administered by the
Administrator. The Administrator shall be responsible for the administration of
all matters under the Plan which have not been delegated to the Agent. The
Administrator shall have full and exclusive discretionary authority to construe,
interpret and apply the terms of the Plan, to determine eligibility and to
adjudicate all disputed claims filed under the Plan. Any rule or regulation
adopted by the Administrator shall remain in full force and effect unless and
until altered, amended or repealed by the Administrator.
b. Specific Responsibilities. The Administrator's responsibilities
shall include, but shall not be limited to:
(1) interpreting the Plan (including issues relating to the
definition and application of "Compensation");
(2) identifying and compiling a list of persons who are Eligible
Employees for an Offering Period;
(3) identifying those Eligible Employees not entitled to be
granted options or other rights for an Offering Period on account
of the limitations described in Section 3 b. hereof; and
(4) providing to Participants upon request Company financial
statements which are publicly available.
The Administrator may from time to time adopt rules and regulations for carrying
out the terms of the Plan. Interpretation or construction of any provision of
the Plan by the Administrator shall be final and conclusive on all persons,
absent specific and contrary action taken by the Board. Any interpretation or
construction of any provision of the Plan by the Board shall be final and
conclusive.
SECTION 19 - SECURITIES LAW AND OTHER RESTRICTIONS
Notwithstanding any provision of the Plan to the contrary, no payroll
deductions or alternative contributions shall take place and no Shares may be
purchased under the Plan until a registration statement has been filed and
become effective with respect to the issuance of the Shares covered by the Plan
under the Act and any other required action has been taken under any other
applicable law of the jurisdiction in which the Employer of the Employee is
located or the Employee is employed or resides. Prior to the effectiveness of
such registration statement, Shares subject to purchase under the Plan may be
offered to Eligible Employees only pursuant to an exemption from the
registration requirements of the Act and pursuant to any other action that is
required under any other applicable law of the jurisdiction in which the
Employer of the Employee is located or the Employee is employed or resides.
SECTION 20 - NO INDEPENDENT EMPLOYEE'S RIGHTS
Nothing in the Plan shall be construed to be a contract of employment
between an Employer or its parent or any Subsidiary and any Employee, or any
group or category of Employees (whether for a definite or specific duration or
otherwise), or to prevent the Employer, its parent or any Subsidiary from
terminating any Employee's employment at any time, without notice or recompense
to the extent permissible under local law.
Page 8
Nothing in this Plan shall be construed as conferring any rights of a
shareholder in any Employee or any other person until the option to purchase
shares granted to the Employee hereunder has been exercised.
SECTION 21 - APPLICABLE LAW
The Plan shall be construed, administered and governed in all respects
under the laws of the State of Ohio to the extent such laws are not preempted or
controlled by federal law.
SECTION 22 - MERGER OR CONSOLIDATION
If the Company shall at any time merge into or consolidate with
another corporation or business entity, each Participant will thereafter be
entitled to receive at the end of the Offering Period (during which such merger
or consolidation occurs) the securities or property which a holder of Shares was
entitled to upon and at the time of such merger or consolidation. A sale of all
or substantially all of the assets of the Company shall be deemed a merger or
consolidation for the foregoing purposes.
Page 9
FIRST AMENDMENT
TO THE
CARDINAL HEALTH, INC. GLOBAL EMPLOYEE STOCK PURCHASE PLAN
Background Information
A. Cardinal Health, Inc., an Ohio corporation (the "Company"), maintains an
employee stock purchase plan known as the Cardinal Health, Inc. Global Employee
Stock Purchase Plan (the "Plan") for the benefit of eligible employees of its
designated subsidiaries.
B. Pursuant to Section 17 of the Plan, the Company may amend the Plan by
action of its Board of Directors, which authority has been delegated by the
Board of Directors to the Financial Benefit Plans Committee of the Company.
C. The Cardinal Health Financial Benefit Plans Committee (the "Committee")
is empowered to amend the Plan on behalf of the Company by action of a majority
of its members then in office and has authorized the amendments set forth herein
and the execution of these amendments by the undersigned.
Amendment to the Plan
Effective as of February 25, 2005, the Cardinal Health, Inc. Global
Employee Stock Purchase Plan is amended in the following respects:
1. Section 10.a is hereby revised to read as follows: "Reinvestment of
Dividends. Subject to applicable law, cash dividends and other cash
distributions received by the Agent on Shares held in its custody hereunder will
be credited to the Plan Accounts of individual Participants in accordance with
such Participants' interests in the Shares with respect to which such dividends
or distributions are paid or made. Cash dividends will be applied, as soon as
practicable after the receipt thereof by the Agent, in accordance with the
directions of the individual Participant to whose Plan Account such amounts have
been credited. Participants may, but are not required to, direct that such cash
dividends be applied to the purchase in the open market at prevailing market
prices of the number of whole Shares capable of being purchased with such funds
(or the portion of such funds designated for such application by the
Participant), after deduction of any bank service fees, brokerage charges,
transfer taxes, and any other transaction fee, expense or cost payable in
connection with the purchase of such Shares and not otherwise paid by the
Employer, and subject to the Company's obligation to withhold federal, state or
other local taxes."
2. In all other respects, the Plan shall remain in full force and effect.
Date: April 7, 2005 CARDINAL HEALTH, INC.
By: /s/ Sue Nelson
------------------------------------
Its: Vice President, Compensation &
Benefits, Secretary, FBPC
Exhibit 10.36
RETENTION AGREEMENT
THIS RETENTION AGREEMENT (this "Agreement") is dated as of August 31, 2004,
by and between David L. Schlotterbeck (the "Employee") and ALARIS Medical
Systems, Inc., a Delaware corporation (the "Company").
RECITALS
WHEREAS, the Employee and the Company executed a letter agreement on May
10, 2000, (the "Change of Control Agreement") providing the Employee with
certain severance benefits in the event of a "change of control" as defined in
the Change of Control Agreement;
WHEREAS, on July 7, 2004, the Company became a wholly-owned subsidiary of
Cardinal Health, Inc. ("Cardinal"), pursuant to that certain Agreement and Plan
of Merger by and among the Company, Blue Merger Corp. and Cardinal dated as of
May 18, 2004 (the "Merger Agreement");
WHEREAS, the Employee is employed by the Company; and
WHEREAS, the Company values the services of the Employee and desires to
provide an inducement to the Employee to work as an employee of the Company for
a period following the Closing (as such capitalized term is defined in the
Merger Agreement).
AGREEMENT
NOW, THEREFORE, in consideration of the foregoing and the mutual covenants,
agreements, representations and warranties herein contained, and for other good
and valuable consideration, the receipt and sufficiency of which is hereby
acknowledged, the parties hereto, intending to be legally bound hereby, do
hereby agree as follows:
1. Retention Program. If the Employee remains employed by the Company,
Cardinal or any other direct or indirect subsidiary of Cardinal (Cardinal and
Cardinal's other subsidiaries are hereinafter referred to as "Affiliated
Companies" and each as an "Affiliated Company") until June 28, 2006 (the "Target
Date"), the Company shall pay to Employee a one-time, lump-sum retention cash
bonus equal to the greater of (a) $2,172,000.00 and (b) the sum of (i) two
hundred percent (200%) of the Employee's base annual pay effective as of the
Target Date and (ii) two hundred percent (200%) of the Employee's target bonus
for the fiscal year ending June 30, 2006 (the "Retention Bonus"). If the
Retention Bonus is earned by the Employee pursuant to this Section 1, the
Retention Bonus will be paid to the Employee within fifteen (15) days following
the Target Date. In addition, if at anytime after June 28, 2006 (the "Target
Date") the Employee voluntarily departs from the Company, the Company shall pay
to the Employee a one time lump sum cash bonus equal to one hundred percent
(100%) of the Employee's base annual pay effective as of the departure date.
2. Change of Control Agreement. The Employee acknowledges and agrees that
by executing this Agreement, the Change of Control Agreement shall be terminated
in its entirety, and the terms and conditions thereof shall be superseded by the
terms and conditions of this Agreement; and that, effective upon the execution
of this Agreement by the Employee, neither the Company nor Cardinal, nor any
other Affiliated Company, shall have any obligation to the Employee, nor shall
the Employee enjoy any rights or privileges, under the Change of Control
Agreement.
3. Termination Prior to the Target Date.
(a) General. Nothing contained in this Agreement shall (i) confer upon
the Employee any right to continue in the employ of the Company, (ii) constitute
any contract or agreement of employment, or (iii) interfere in any way with the
at-will nature of the Employee's employment with the Company. The parties hereto
acknowledge, understand and agree that (so long as it is done in accordance with
applicable law) the Company may terminate the Employee's employment at any time
for any reason or for no reason with or without notice and that the Employee may
terminate the Employee's employment with the Company at anytime for any reason
or for no reason with or without notice, including, without limitation, in each
case, for Disability (as hereinafter defined), but only if that Disability
continues through the Date of Termination (as hereinafter defined). The Employee
shall be entitled to the benefits provided in Section 4 upon a termination of
the Employee's employment if that termination occurs on or prior to the Target
Date, but only if that termination was effected (i) by the Company other than
for Cause (as defined below); (ii) by the Employee for Good Reason (as defined
below); (iii) by the Employee's death; or (iv) by the Company for Disability (as
defined below) (a termination of the Employee's employment under the
circumstances set forth in clause (i), (ii), (iii) or (iv) of this sentence is
hereinafter referred to as a "Payment Termination"). The Employee shall not be
entitled to the benefits provided in Section 4: (i) if the Employee's employment
is terminated for any reason after the Target Date or (ii) the Employee's
employment is terminated on or prior to the Target Date, if such termination is
occasioned: (A) by the Company for Cause or (B) by the Employee for other than
Good Reason. A termination of the Employee's employment under the circumstances
set forth in clause (A) or (B) above is hereinafter referred to as a
"Non-Payment Termination").
(b) Death or Disability. The Employee's employment with the Company
shall terminate, automatically, upon the Employee's death. For purposes hereof
the term "Disability" shall mean the Employee's absence from the full-time
performance of the Employee's duties with the Company for six (6) consecutive
months as set forth in the Company's disability plan, a copy of which is
available to the Employee.
(c) Cause. The Company may terminate the Employee's employment for any
reason or for no reason, including, without limitation, for Cause. For purposes
of this Agreement, "Cause" shall mean (i) any breach by the Employee of any of
the Employee's obligations under this Agreement of a type and kind which is
materially adverse to the Company and which remains uncured by the Employee for
thirty (30) calendar days following the Employee's receipt of Notice of
Termination (as hereinafter defined); (ii) any gross misconduct by the Employee
of a type and kind which is materially adverse to the Company; (iii) any
violation by the Employee of a governmental law, rule or regulation applicable
to the business of the Company of a type and kind which is materially adverse to
the Company; or (iv) the Employee's conviction of, or entry by the Employee of a
guilty, or no contest, plea to, the commission of a felony of a kind that causes
material impairment or injury or substantial embarrassment to the Company.
(d) Good Reason. The Employee may terminate the Employee's employment
for any reason or for no reason, including, without limitation for Good Reason.
For purposes of this Agreement, "Good Reason" shall mean the occurrence after
the Closing occurring on or before the Target Date of any one or more of the
following events without, in each case, the Employee's prior written consent:
2
i. the assignment to the Employee of any duties (other than
duties constituting reasonable transition services in connection with the
consummation of the transaction anticipated by the Merger Agreement) which are
inconsistent with the position in the Company that the Employee held immediately
prior to the Closing, an alteration in the nature or status of the Employee's
responsibilities or the conditions of the Employee's employment from those in
effect immediately prior to the Closing, or any other action by the Company that
results in a diminution in the position and authority with the Company held by
the Employee prior to the Closing, in each case, under circumstances in which
such assignment, alteration or action is materially adverse to the Employee;
provided, however, that, for purposes of this Section, the fact that the
Employee is no longer an employee of a "publicly-traded" company shall not be
deemed to be an alteration in the Employee's responsibilities or conditions or a
diminution in position or authority;
ii. the Company's reduction of the Employee's annual base salary
or bonus opportunity, each as in effect on the Closing Date or as the same may
be increased from time to time;
iii. the relocation of the Company's offices at which the
Employee is principally employed immediately prior to the Closing (the
Employee's "Principal Location") to a location more than ten (10) miles from the
Principal Location, or the Company's requiring the Employee to be based at a
location more than ten (10) miles from the Employee's Principal Location, except
for required travel on the Company's business to an extent substantially
consistent with the Employee's present business travel obligations;
iv. the Company's failure to pay to the Employee any portion of
the Employee's current compensation or any portion of an installment of deferred
compensation under any deferred compensation program of the Company within seven
(7) days following the later of the date such compensation is due or the date of
written demand by the Employee for the payment of such compensation
(specifically referring to this Section 3(d)(iv));
v. the Company's failure to continue in effect compensation and
benefit plans which provide the Employee with benefits which are substantially
similar, on an aggregate basis, to the benefits provided to the Employee under
the Company's regular compensation and benefit plans and practices immediately
prior to the Closing, unless an equitable arrangement (embodied in ongoing
substitute or alternative plans) has been made with respect to such plans, or
the Company's failure to continue the Employee's participation therein (or in
such substitute or alternative plans) on a basis not materially less favorable
in the aggregate, both in terms of the amount of benefits provided and the level
of the Employee's participation relative to other participants, as existed at
the time of the Closing;
vi. any purported termination of the Employee's employment by the
Company which does not satisfy the requirements of Section 3(e) hereof (such a
purported termination shall not be effective for purposes of this Agreement);
vii. the continuation or repetition, after written notice of
objection from the Employee (specifically referring to this Section 3(d)(vii)),
of harassing or denigrating treatment of the Employee inconsistent with the
Employee's position with the Company, which treatment is materially adverse to
the Employee; or
viii. any breach by the Company of its obligations under this
Agreement which is materially adverse to the Employee and which remains uncured
by the
3
Company for five (5) calendar days following the Company's receipt of notice
thereof (specifically referring to this Section 3(d)(viii)).
In addition, in the event that the Employee has become Disabled on or before the
Target Date, the Employee may terminate the Employee's employment on or before
the Target Date and such termination shall be deemed to be for Good Reason.
Further, the Employee's continued employment shall not constitute consent to, or
a waiver of right with respect to, any circumstance constituting Good Reason
hereunder.
(e) Notice of Termination. Any purported termination of the Employee's
employment by the Company or by the Employee (other than termination due to the
Employee's death, since the Employee's death terminates the Employee's
employment automatically) occurring on or before the Target Date shall be
communicated by written Notice of Termination to the other party hereto in
accordance with Section 7. For purposes of this Agreement, "Notice of
Termination" means a notice that shall indicate the specific termination
provision in this Agreement relied upon, shall set forth in reasonable detail
the facts and circumstances claimed to provide a basis for termination of the
Employee's employment under the provision so indicated and shall set forth a
date (the "Date of Termination") which follows the date of that notice. If,
notwithstanding the foregoing, the Employee's employment is being terminated by
the Employee for Good Reason, the Date of Termination may not be more than
thirty (30) days from the date of that notice or more than three (3) months from
the date of the events giving rise to that Good Reason, whichever first occurs.
(f) Date of Termination. If the Company seeks to terminate the
Employee's employment for Cause, the date of termination of the Employee's
employment shall be the Date of Termination, except that if the consequences of
the act or omission to act set forth in the pertinent Notice of Termination is
curable (and cure is allowed under such circumstances) then the date of
termination of the Employee's employment shall be the date which is the
thirty-first (31st) day following the Date of Termination, unless the Employee
shall have cured such consequences prior to that date, in which case the
Employee's employment shall not terminate. Subject to a different date set forth
in a Notice of Termination provided under Section 3(e), if the Employee seeks to
terminate the Employee's employment with the Company for Good Reason, the date
of termination of the Employee's employment shall be the Date of Termination.
The date that the Employee's employment actually terminates is hereinafter
referred to herein as the "Final Date".
4. Compensation upon Termination.
(a) Non-Payment Termination. In the event of a Non-Payment
Termination, the Company shall pay to Employee the Employee's full base salary,
when due, through the Final Date at the rate in effect immediately prior to the
delivery of the pertinent Notice of Termination, if a Notice of Termination was
required to have been given, or if it was not, then on the Final Date, plus all
other amounts to which the Employee is entitled under any compensation plan of
the Company at the time such payments are due, and the Company shall have no
further obligations to the Employee under Section 1 or otherwise under this
Agreement.
(b) Payment Termination. In the event of a Payment Termination, then,
subject to Section 4(e) and in lieu of any severance benefits to which the
Employee may otherwise be entitled under any severance plan or program of the
Company, the Employee shall
4
be entitled to the benefits provided below, and the Company shall have no
further obligations to the Employee under Section 1 or otherwise under this
Agreement:
i. the Company shall pay to Employee the Employee's full base
salary, when due, through the Final Date at the rate in effect immediately prior
to the delivery of the pertinent Notice of Termination (or if the Employee's
termination is for Good Reason by reason of a reduction in the Employee's annual
base salary, the rate in effect immediately prior to such reduction), at the
time specified in Section 4(c), plus all other amounts (other than severance
benefits not provided for in this Agreement) to which the Employee is entitled
under any compensation plan of the Company at the time such payments are due;
ii. in lieu of any further salary payments to the Employee for
periods subsequent to the Final Date, the Company shall pay as severance pay to
the Employee, at the time specified in Section 4(c), a one-time, lump-sum
severance payment equal to the greater of (1) $2,172,000.00 and (2) the sum of
(A) two hundred percent (200%) of the Employee's annual base salary as in effect
immediately prior to the delivery of the pertinent Notice of Termination (or if
the Employee's termination is for Good Reason by reason of a reduction in the
Employee's annual base salary, the rate in effect immediately prior to such
reduction) and (B) two hundred percent (200%) of the Employee's targeted annual
aggregate bonus amounts for the fiscal year ending June 30, 2006 (or if the
Employee's termination is for Good Reason by reason of a reduction in the
Employee's bonus opportunity, the bonus opportunity in effect immediately prior
to such reduction). In addition, the Company shall pay to the Employee a one
time lump sum cash bonus equal to one hundred percent (100%) of the Employee's
base annual pay effective as of the Notice of Termination date.
iii. the Company shall, at its sole expense as incurred, provide
the Employee with outplacement services for a period not to exceed nine (9)
consecutive months immediately following the Final Date at an aggregate cost to
the Company not to exceed $12,000, the scope of which shall be selected by the
Employee in the Employee's sole discretion and the provider of which shall be
selected by the Employee from among the providers offered to the Employee by the
Company;
iv. for the period beginning on the Final Date and ending on the
earlier of (A) the date which is twenty-four (24) full months following the
Final Date or (B) the first day of the Employee's eligibility to participate in
another group health plan, the Company shall pay for and provide the Employee
and the Employee's dependents with the same medical benefits coverage to which
the Employee would have been entitled had the Employee remained continuously
employed by the Company during such period. In the event that the Employee is
ineligible under the terms of the Company's benefit plans to continue to be so
covered, the Company shall provide the Employee with substantially equivalent
coverage through other sources or will provide the Employee with a lump sum
payment (determined on a present value basis using the interest rate provided in
Section 1274(b)(2)(B) of the Internal Revenue Code (the "Code") on the Date of
Termination) in such amount that, after all income and employment taxes on that
amount, shall be equal to the cost to the Employee of providing the Employee
such benefit coverage. At the termination of the benefits coverage under the
first sentence of this Section 4(b)(iv), the Employee and the Employee's
dependents shall be entitled to continuation coverage ("COBRA Coverage")
pursuant to Section 4980B of the Code, Sections 601-608 of the Employee
Retirement Income Security Act of 1974, as amended, and under any other
applicable law, to the extent required by such laws, as if the Employee had
terminated employment with the Company on the date such benefits coverage
terminates; provided, however, that the period of the
5
Employee's benefits coverage under the first sentence of this Section 4(b)(iv)
shall be offset against the period during which the Employee would be entitled
to such COBRA Coverage; and
v. the Employee shall be fully vested in the Employee's accrued
benefits under any qualified or nonqualified pension, profit sharing, deferred
compensation or supplemental plans maintained by the Company for the Employee's
benefit; provided, however, that to the extent that the acceleration of vesting
of such benefits would violate any applicable law or require the Company to
accelerate the vesting of the accrued benefits of all participants in such plan
or plans, then, assuming that the Employee obtains the appropriate consents, the
Company shall pay the Employee a lump-sum payment at the time specified in
Section 4(c) in an amount equal to the value of such unvested benefits.
(c) Timing of Payment. The payments provided for in Sections 4(b)(i),
(ii) and (v) (if applicable) shall be made not later than the fifth (5th)
business day following the Final Date; provided, however, that if the amounts of
such payments cannot be finally determined on or before such date, the Company
shall pay to the Employee on such day an estimate, as determined in good faith
by the Company, of the minimum amount of such payments and shall pay the
remainder of such payments (together with interest at the rate provided in
Section 1274(b)(2)(B) of the Code) as soon as the amount thereof can be
determined but in no event later than the thirtieth (30th) day after the Final
Date. In the event that the amount of the estimated payments exceeds the amount
subsequently determined to have been due, such excess shall constitute a loan by
the Company to the Employee, payable on the fifth (5th) business day after
demand by the Company (together with interest at the rate provided in Section
1274(b)(2)(B) of the Code).
(d) No Mitigation. The Employee shall not be required to mitigate the
amount of any payment provided for in this Section 4 by seeking other employment
or otherwise nor, except as provided in Section 4(b)(iv), shall the amount of
any payment or benefit provided for in this Section 4 be reduced by any
compensation earned by the Employee as the result of employment by another
employer or self-employment, by retirement benefits, by offset against any
amounts (other than loans or advances to the Employee by the Company) claimed to
be owed by the Employee to the Company, or otherwise.
(e) Treatment of Payment.
i. Notwithstanding anything contained herein, if any payment or
distribution to the Employee or for the Employee's benefit (whether paid or
payable or distributed or distributable) pursuant to the terms of this Section 4
(a "Payment") would constitute a "parachute payment" within the meaning of
Section 280G of the Code, the Payments shall be reduced to the extent necessary
so that no portion of the Payments shall be subject to the excise tax imposed by
Section 4999 of the Code (the "Excise Tax"), but only if, by reason of such
reduction, the net after-tax benefit to the Employee shall exceed the net
after-tax benefit to the Employee if no such reduction was made. For purposes of
this Section 4(e), "net after-tax benefit" shall mean (A) the Payments which the
Employee receives or is then entitled to receive that would constitute
"parachute payments" within the meaning of Section 280G of the Code, less (B)
the amount of all federal, state, local and foreign income and employment taxes
payable with respect to the foregoing calculated at the maximum marginal income
tax rate for each year in which the foregoing shall be paid to the Employee
(based on the rate in effect for such year as set forth in the Code as in effect
at the time of the first payment of the foregoing), less (C) the amount of the
Excise Tax imposed with respect to the Payments. The foregoing determination
will be made by the Accountants (as defined below) in consultation with the
Employee and the Company and in accordance with the analysis, valuations and
calculations prepared by the
6
Accountants in connection with this Agreement. If the Accountants determine that
such reduction is required by this Section 4(e)(i), the Employee, in the
Employee's sole and absolute discretion, may determine which Payments shall be
reduced to the extent necessary so that no portion thereof shall be subject to
the Excise Tax, and the Company shall pay such reduced amount to the Employee.
The Employee and the Company will each provide the Accountants access to and
copies of any books, records, and documents in the possession of the Employee or
the Company, as the case may be, reasonably requested by the Accountants, and
otherwise cooperate with the Accountants in connection with the preparation and
issuance of the determinations and calculations contemplated by this Section
4(e)(i).
ii. All determinations required to be made under this Section
4(e), including the assumptions to be utilized in arriving at such
determinations, shall be made by the Accountants which shall provide the
Employee and the Company with its determinations and detailed supporting
calculations with respect thereto at least fifteen (15) business days prior to
the date on which the Employee would be entitled to receive a Payment (or as
soon as practicable in the event that the Accountants have less than fifteen
(15) business days advance notice that the Employee may receive a Payment) in
order that the Employee may determine whether the Employee concurs with such
determination. For the purposes of this Section 4(e), the "Accountants" shall
mean the Company's independent certified public accountants serving immediately
prior to the Final Date. All fees and expenses of the Accountants shall be borne
solely by the Company. For the purposes of determining whether any of the
Payments will be subject to the Excise Tax and the amount of such Excise Tax,
such Payments will be treated as "parachute payments" within the meaning of
Section 280G of the Code, and all "parachute payments" in excess of the "base
amount" (as defined under Section 280G(b)(3) of the Code) shall be treated as
subject to the Excise Tax, unless and except to the extent that in the opinion
of the Accountants such Payments (in whole or in part) either do not constitute
"parachute payments" or represent reasonable compensation for services actually
rendered (within the meaning of Section 280G(b)(4) of the Code) in excess of the
"base amount," or such "parachute payments" are otherwise not subject to such
Excise Tax. Any determination by the Accountants shall be binding upon the
Company and the Employee. As a result of uncertainty in the application of
Section 4999 of the Code at the time of the initial determination by the
Accountants hereunder, it is possible that the amount of the Payments that the
Accountants determine would constitute a "parachute payment" within the meaning
of Section 280G of the Code will have been less than the amount of the Payments
that the Internal Revenue Service (the "IRS") determines constitutes a
"parachute payment" within the meaning of Section 280G of the Code. In such
event, the Employee shall notify the Company in writing of any such claim by the
IRS. Such notification shall be given as soon as practicable after the Employee
is informed in writing of such claim and shall apprise the Company of the nature
of such claim and the date on which such claim is requested to be paid. In
connection with any contest or potential contest of such claim, the Employee and
the Company will provide each other access to and copies of any books, records,
and documents in the possession of the Employee or the Company, as the case may
be, reasonably requested by the other party, and will otherwise cooperate with
each other in connection with any such contest or potential contest. In the
event that the Employee or the Company contest such claim, the Company shall
bear and pay directly all costs and expenses (including additional interest and
penalties) incurred in connection with such contest. If it is finally determined
that the amount of the Payments that the Accountants determined constituted a
"parachute payment" within the meaning of Section 280G of the Code is less than
the amount of the Payments that the IRS determined constituted a "parachute
payment" within the meaning of Section 280G of the Code, the Employee shall
repay to the Company (together with interest at the rate provided in Section
1274(b)(2)(B) of the Code) that amount of the Payments necessary to reduce the
Payments such that no portion thereof shall be subject to the Excise Tax, but
only if,
7
by reason of such repayment, the net after-tax benefit to the Employee shall
exceed the net after-tax benefit to the Employee if no such repayment was made.
Nothing contained in this Section 4(e)(ii) shall limit the Employee's ability or
entitlement to settle or contest, as the case may be, any claim or issue
asserted or raised by the IRS or any other taxing authority.
(f) Release. Notwithstanding anything to the contrary contained
herein, as a condition to the effectiveness of this Retention Agreement, the
Employee agrees to execute the Release and Waiver of Claims attached hereto as
Exhibit A (the "Release"), which releases the Company from any and all claims,
liabilities and obligations that may have arisen due to events occurring prior
to the Employee's execution of the Release.
5. Stock Options; Eligibility for Annual Merit Reviews and Incentive Plans.
(a) Stock Options. Notwithstanding anything contained herein, all
outstanding options, if any, granted to the Employee under any of the Company's
stock option plans, incentive plans or other similar plans (or options
substituted therefor covering the stock of a successor corporation) shall
continue to be subject to the terms, provisions and limitations of the
applicable stock option plan and option agreement.
(b) Annual Merit Review; Incentive Plans. The Employee shall continue
to be eligible for annual merit reviews and Company incentive plans.
6. Successors; Binding Agreement.
(a) The Company shall require any successor thereof (whether direct or
indirect, by purchase, merger, consolidation or otherwise (a "Change of
Control")) to all or substantially all of the business and/or assets of the
Company to expressly assume and agree to pay and perform, when due, all of the
obligations of the Company to the Employee under this Agreement incurred in
connection with a Change of Control to such successor, to the extent such a
Change of Control occurs on or prior to the Target Date. For the avoidance of
doubt, the Company's obligations under this Section 6(a) shall not be triggered
by a Change of Control of Cardinal or any of other Affiliated Company (other
than the Company).
(b) This Agreement shall inure to the benefit of and be enforceable by
the Employee and the Employee's personal or legal representatives, executors,
administrators, successors, heirs, distributees, devisees and legatees. If the
Employee should die while any amount would still be payable to the Employee
hereunder had the Employee continued to live, all such amounts, unless otherwise
provided herein, shall be paid in accordance with the terms of this Agreement to
the Employee's devisee, legatee or other designee or, if there is no such
designee, to the Employee's estate.
7. Notice. For the purpose of this Agreement, notices and all other
communications provided for in this Agreement shall be in writing and shall be
deemed to have been duly given when delivered or mailed by United States
certified or, registered mail, return receipt requested, postage prepaid,
addressed to the respective addresses set forth on the signature page of this
Agreement, provided that all notices to the Company shall be directed to the
attention of the Board with a copy to the Secretary of the Company, or to such
other address as either party may have furnished to the other in writing in
accordance herewith, except that notice of change of address shall be effective
only upon receipt.
8
8. Confidentiality; Non-Solicitation.
(a) The Employee hereby agrees to continue to be bound by the terms
and conditions of the Confidentiality and Invention Assignment Agreement by and
between the Company and the Employee dated May 10, 2000, attached hereto as
Exhibit B (the "Confidentiality and Invention Assignment Agreement").
(b) The Employee hereby agrees that, for the period commencing on the
Final Date and terminating on the twelve (12) month anniversary thereof, the
Employee shall not, either on the Employee's own account or jointly with or as a
manager, agent, officer, employee, consultant, partner, joint venturer, owner or
shareholder or otherwise on behalf of any other person, firm or corporation,
directly or indirectly solicit or attempt to solicit away from the Company any
of its officers or employees or offer employment to any person who, on or during
the six (6) months immediately preceding the date of such solicitation or offer,
is or was an officer or employee of the Company; provided, however, that a
general advertisement to which an employee of the Company responds shall in no
event be deemed to result in a breach of this Section 8. Such agreement by the
Employee shall not be deemed to limit in any way any other non-solicitation or
similar agreement between the Employee and the Company.
(c) The provisions of this Section 8 shall survive the termination or
expiration of this Agreement and the Employee's employment with the Company and
shall be fully enforceable thereafter. If it is determined by a court of
competent jurisdiction in any state or jurisdiction that any restriction in this
Section 8 is excessive in duration or scope or is unreasonable or unenforceable
under the laws of that state or jurisdiction, it is the intention of the parties
that such restriction may be modified or amended by the court to render it
enforceable to the maximum extent permitted by the law of that state or
jurisdiction.
(d) In the event that the Employee shall breach or threaten to breach
any of the provisions of this Section 8, in addition to and without limiting or
waiving any other remedies available to the Company in law or in equity, the
Company shall be entitled to immediate injunctive relief in any court, domestic
or foreign, having the capacity to grant such relief, to restrain such breach or
threatened breach and to enforce the provisions of this Section 8. The Employee
acknowledges that it is impossible to measure in money the damages that the
Company will sustain in the event that the Employee breaches or threatens to
breach the provisions of this Section 8 and, in the event that the Company shall
institute any action or proceeding to enforce such provisions seeking injunctive
relief, the Employee hereby waives and agrees not to assert and shall not use as
a defense thereto the claim or defense that the Company has an adequate remedy
at law. The foregoing shall be in addition to any remedies available to the
Company at law or in equity.
9. "At-Will" Relationship Unchanged. The Employee and the Company
acknowledge and agree that the Employee's employment relationship with the
Company shall be and shall remain "at-will" and nothing in this Agreement is
intended to, nor shall be construed to, change the status of that relationship.
Without limiting the generality of the foregoing, the Employee and the Company
shall each be entitled to terminate the Employee's employment relationship with
the Company at any time, with or without notice, for any reason or for no reason
whatsoever.
10. Entire Agreement. This Agreement sets forth the entire agreement of the
parties hereto in respect of the subject matter contained herein and, except (a)
for the provisions of the Confidentiality and Invention Assignment Agreement,
which provisions shall be supplemented
9
by this Agreement and shall not be superseded by the provisions herein and (b)
as otherwise expressly provided herein, supersedes all prior agreements,
promises, covenants, arrangements, communications, representations or
warranties, whether oral or written, by any officer, employee or representative
of any party hereto; and any prior agreement of the parties hereto in respect of
the subject matter contained herein, including, without limitation, any prior
change of control agreements or severance agreements, including, but not limited
to, the Change of Control Agreement, is hereby terminated and canceled. No
amendment, modification or waiver of any provision of this Agreement, shall be
effective unless the same shall be in writing and signed by the Company and the
Employee.
11. Severability. The invalidity or unenforceability of any provision of
this Agreement shall not affect the validity or enforceability of any other
provision of this Agreement, which shall remain in full force and effect.
12. Counterparts. This Agreement may be executed in multiple counterparts,
each of which shall be deemed an original, but all of which taken together shall
be one and the same instrument.
13. Payments. Any payments provided for hereunder shall be paid net of any
applicable withholding required under federal, state, local or foreign law.
14. Governing Law. This Agreement shall be governed by the laws of the
State of California, without regard to principles of conflicts of law.
15. Headings; References. The section headings contained in this Agreement
are for convenience only, and shall not affect the interpretation of this
Agreement. All references to sections of the Code shall be deemed also to refer
to any successor provisions to such sections.
16. Acknowledgement. The Employee acknowledges (a) that the Employee has
consulted with or has had the opportunity to consult with independent counsel of
the Employee's own choice concerning this Agreement, and (b) that the Employee
has read and understands the Agreement, is fully aware of its legal effect, and
has entered into it freely based on the Employee's own judgment and not on any
representations or promises other than those contained in this Agreement.
[SIGNATURE PAGE FOLLOWS]
10
IN WITNESS WHEREOF, the undersigned, intending to be legally bound,
have executed this Retention Agreement as of the date first set forth above.
COMPANY: EMPLOYEE:
ALARIS Medical Systems, Inc.
By: /s/ George Fotiades By: /s/ Dave Schlotterbeck
--------------------------------- ------------------------------------
Name: George Fotiades Name: Dave Schlotterbeck
Title: Cardinal Health, President and
COO
Date: 9-8-04 Date: 8-31-04
Address: 7000 Cardinal Place Address: [Intentionally omitted]
Dublin Ohio 43017
EXHIBIT A
RELEASE AND WAIVER OF CLAIMS
[Attached]
EXHIBIT B
CONFIDENTIALITY AND INVENTION ASSIGNMENT AGREEMENT
[Attached]
RELEASE AND WAIVER OF CLAIMS
In consideration of entering into the Retention Agreement by and between
David L. Schlotterbeck and ALARIS Medical Systems, Inc., a Delaware corporation
(the "Company"), substantially in the form attached hereto as Exhibit A (the
"Retention Agreement"), I, DAVID L. SCHLOTTERBECK, hereby furnish the Company
with the following release and waiver ("Release and Waiver").
1. In exchange for the consideration provided to me by the Company set
forth in the Retention Agreement that I am not otherwise entitled to receive, I
hereby generally and completely release the Company and its directors, officers,
employees, shareholders, partners, agents, attorneys, predecessors, successors,
parent and subsidiary entities, insurers, affiliates, and assigns from any and
all claims, liabilities and obligations, both known and unknown, that arise out
of or are in any way related to events, acts, conduct, or omissions occurring
prior to my signing this Release and Waiver that arise out of or relate to my
employment relationship with the Company. This general release includes, but is
not limited to:
(a) all claims arising out of or in any way related to my
employment with the Company or the termination of that employment;
(b) all claims related to my compensation or benefits from the
Company, including salary, bonuses, commissions, vacation pay, expense
reimbursements, severance pay, fringe benefits, or any ownership interests
in the Company (as I acknowledge that I have received all compensation or
benefits owed to me);
(c) all claims for breach of contract, wrongful termination, and
breach of the implied covenant of good faith and fair dealing;
(d) all tort claims, including claims for fraud, defamation,
emotional distress, and discharge in violation of public policy; and
(e) all federal, state, and local statutory claims, including
claims for discrimination, harassment, retaliation, attorneys' fees, or
other claims arising under the federal Civil Rights Act of 1964 (as
amended), the federal Americans with Disabilities Act of 1990, the federal
Age Discrimination in Employment Act of 1967 (as amended) ("ADEA"), the
California Fair Employment and Housing Act (as amended), the Americans with
Disabilities Act (as amended), the federal Civil Rights Act of 1991 (as
amended), the federal Family and Medical Leave Act of 1993 (as amended),
the federal Consolidated Omnibus Budget Reconciliation Act of 1986 (as
amended), the federal National Labor Relations Act of 1935 (as amended),
the federal Labor Management Relations Act of 1947 (as amended), the
federal Equal Pay Act of 1963 (as amended), the federal Employee Retirement
Income Security Act of 1974 (as amended), the federal Older Workers'
Benefit Protection Act of 1990 (as amended), the federal Fair Labor
Standards Act of 1938 (as amended) and the California Labor Code (as
amended).
1
2. I also acknowledge that I have read and understand Section 1542 of the
California Civil Code which reads as follows:
"A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR DOES NOT
KNOW OR SUSPECT TO EXIST IN HIS FAVOR AT THE TIME OF EXECUTING THE RELEASE,
WHICH IF KNOWN BY HIM MUST HAVE MATERIALLY AFFECTED HIS SETTLEMENT WITH THE
DEBTOR."
I hereby expressly waive and relinquish all rights and benefits under that
section and any law of any jurisdiction of similar effect with respect to any
claims I may have against the Company.
3. I acknowledge that, among other rights, I am waiving and releasing any
rights I may have under ADEA, that this Release and Waiver is knowing and
voluntary, and that the consideration given for this Release and Waiver is in
addition to anything of value to which I was already entitled as an executive of
the Company. Since I am forty (40) years of age or older upon execution of this
Release and Waiver, I further acknowledge that I have been advised, as required
by the Older Workers Benefit Protection Act, that: (a) the release and waiver
granted herein does not relate to claims under the ADEA which may arise after
this Release and Waiver is executed; (b) I have the right to consult with an
attorney prior to executing this Release and Waiver (although I may choose
voluntarily not to do so); (c) I have twenty-one (21) days from the date of
termination of my employment with the Company in which to consider this Release
and Waiver (although I may choose voluntarily to execute this Release and Waiver
earlier); (d) I have seven (7) days following the execution of this Release and
Waiver to revoke my consent to this Release and Waiver in writing and delivered
to the Company at 10221 WATERIDGE CIRCLE SAN DIEGO, CA 92121; and (e) this
Release and Waiver, and any benefits accorded herein and in Exhibit A, shall not
be effective until the seven (7) day revocation period has expired.
DATE: 8-31-04 /s/ David L. Schlotterbeck
----------------------------------------
(SIGNATURE)
David L. Schlotterbeck
(PRINT NAME)
2
EXHIBIT A
RETENTION AGREEMENT
[Attached]
3
(ALARIS MEDICAL(R) LOGO)
CONFIDENTIALITY AND INVENTION ASSIGNMENT AGREEMENT
In consideration of my employment by ALARIS Medical Systems, Inc. or any of
its predecessors, successors, assigns, parents, affiliates or subsidiary
companies (collectively, the "Company"), and the opportunity to participate in
product and business development projects, and the compensation paid to me by
the Company:
1. I understand and acknowledge that the Company has and will develop,
compile and own certain proprietary techniques and information which have great
value to its business and which are not generally known to the public (such
techniques and information are hereafter referred to, collectively, as
"Confidential Information"). All Confidential Information generated by me during
my employment, or by other employees of the Company, shall be the sole property
of the Company and its assigns. I understand that the Company has its own
Confidential Information and will also have access to Confidential Information
of third parties, such as persons or entities for whom the Company performs
services or provides products (collectively, "Third Parties"). As used in this
Agreement, Confidential Information shall be broadly defined and shall include
all information that has or could have commercial value or other utility in the
business in which the Company or Third Parties are engaged or contemplate
becoming engaged. Confidential Information also includes all information, the
unauthorized disclosure of which could be detrimental to the interests of the
Company or Third Parties, whether or not such information is identified as
Confidential Information by the Company or Third Parties. By example and without
limitation, Confidential Information includes any and all information relating
to techniques, processes, drawings, designs, formulas, trade secrets,
innovations, inventions, discoveries, improvements, research and development and
test results, programs and code specifications, equipment, prototypes, data,
know-how, formats, marketing plans, business plans, strategies, forecasts,
unpublished financial information, budgets, projections, and customer and
supplier information, identities, characteristics and agreements.
2. I hereby agree to regard and preserve as confidential all Confidential
Information obtained by me, and not to publish or disclose any part of same to
others or use or assist others to use, either directly or indirectly, any
Confidential Information for my own purpose or purposes of others during the
term of this employment or thereafter. Further, both during my employment and
thereafter, I will refrain from any acts or omissions that would reduce the
value of such Confidential Information to the Company. I further agree not to
cause the transmission, removal or transport of Confidential Information from
the Company's principal place of business, or such other place of business
specified by the Company, without prior written approval of an authorized
officer of the Company. In the event that I desire to publish the results of my
work for the Company through literature or speeches, I agree to submit such
literature or speeches to the General Counsel of the Company at least 10
business days before dissemination of such information for determination of
whether such disclosure may jeopardize trade secret status or be prejudicial to
the interest of the Company or Third Parties or whether disclosure may
constitute an invasion of privacy of any individual. I agree not to publish,
disclose or otherwise disseminate such information without prior written
approval of the President or General Counsel of the Company. I acknowledge that
the unauthorized disclosure of Confidential Information may be prejudicial to
the interest of the Company or Third Parties and may be an improper disclosure
of trade secrets. I acknowledge that any information of the Company or Third
Parties which is not readily available to the public shall be considered by me
to be Confidential Information unless the Company advises me otherwise.
3. I hereby agree promptly to disclose to the Company in writing, all
inventions, improvements, developments, designs, ideas, innovations, processes,
techniques, know-how, data, and discoveries, whether or not patentable or
registerable under copyright or similar statutes, that are made, learned,
conceived or reduced to practice by me while in the Company's employ, and for a
period of twelve (12) months after termination of my employment, either solely
or jointly with others, and whether or not during regular working hours
(collectively, "Company Inventions"). "Company Inventions" shall not include any
idea or invention for which no equipment, supplies, facilities, or trade secret
information of the Company was used and which was developed entirely on my own
time, and: (a) which does not relate (i) to the business of the Company, or (ii)
to the Company's actual or demonstrably anticipated research or development; or
(b) which does not result from any work performed by me for the Company.
Furthermore, for California employees only, a Company Invention shall not
include any invention that qualifies fully under the provisions of California
Labor Code Section 2870, a copy of which is attached hereto. For Washington
employees and Washington residents only, a Company Invention shall not include
any invention that qualifies fully under the provisions of Revised Code of
Washington Section 49.44.140, a copy of which is attached hereto.
4. I hereby acknowledge and agree that all Company Inventions belong to and
are the sole property of the Company. I hereby assign, and agree to assign, to
the Company all my right, title, and interest in and to all such Company
Inventions defined above. I will keep complete, accurate and authentic accounts,
notes, data, and records of any and all such Company Inventions in the manner
and form requested by the Company. Such accounts, notes, data and records,
including all copies, shall be the property of the Company, and, upon its
request, I will promptly surrender them to it, or if not previously surrendered,
I will promptly surrender them to the Company at the conclusion of my
employment.
1
5. I further agree that upon request and without compensation therefor, but
at no expense to me, and whether during the term of my employment or thereafter,
I will do all lawful acts, including the execution of papers and lawful oaths
and the giving of testimony, that in the opinion of the Company may be necessary
or desirable in obtaining, sustaining, reissuing, extending, and enforcing
United States and foreign Letters Patent, including Design Patents, on all of
such Company Inventions and for perfecting, affirming, maintaining and recording
the Company's complete ownership and title thereto, and to otherwise cooperate
in all proceedings and matters relating thereto. I further agree that title to
any and all copyrights, copyright registrations, original works of authorship,
and copyrightable subject matter which occur, arise out of or are created as a
result of my employment by the Company shall be the sole and exclusive property
of the Company, and that such works comprise "works made for hire," as that term
is defined in the United States Copyright Act. I hereby assign and agree to
assign all of said copyrights, registrations and subject matter to the Company.
In the event the Company is unable to secure my signature, for any cause, on any
documents necessary to apply for, prosecute, obtain or enforce any patent,
copyright or other right or protection relating to any Company Invention, I
hereby irrevocably designate and appoint the Company and each of its duly
authorized officers and agents as my agent and attorney-in-fact to act for and
in my behalf and stead to execute and file any such document and to do all other
lawfully permitted acts to further the prosecution, issuance and enforcement of
patents, copyrights or other right or protections with the same force and effect
as if executed and delivered by me.
6. As to any Company Inventions made by me which were made, developed,
devised, conceived or reduced to practice during the period of my employment by
the Company, and up to and including twelve (12) months after termination of my
employment, but which are claimed for any reason to belong to an entity or
person other than the Company, I will promptly disclose the same in writing to
the Company and shall not disclose the same to others if the Company, within
twenty (20) days thereafter, shall claim ownership of such inventions under the
terms of this Agreement. If the Company makes such claim, I agree that any
controversy relating to such claim will be settled and determined by binding
arbitration.
7. I understand that the Company may enter into agreements or arrangements
with agencies of the United States Government (including, but not limited to,
the National Aeronautics and Space Administration, the Atomic Energy Commission,
and the Department of Defense or Departments thereof), and that the Company may
be subject to laws and regulations which impose obligations, restrictions and
limitations on it with respect to inventions and patents which may be acquired
by it or which may be conceived or developed by employees, consultants or other
agents rendering services to it. I agree that I shall be bound by all such
obligations, restrictions and limitations applicable to any such invention
conceived or developed by me during the period of my employment and shall take
any and all further action which may be required to discharge those obligations
and to comply with those restrictions and limitations.
8. I agree that upon termination of my employment with the Company, I will
return to the Company promptly and without request all things belonging to the
Company, and that all documents, records, notebooks, and similar repositories of
or containing Confidential Information, including all copies thereof, then in my
possession, whether prepared by me or others, will be left with the Company. I
further agree that I will attend an exit interview, if requested. At the
conclusion of my employment with the Company, I agree to give a written
statement to the Company certifying that I have complied with my obligations
under this Agreement as set forth above and acknowledging my continuing
obligations to disclose Company Inventions, to do certain lawful acts relating
to United States and foreign Letters Patent on the Company Inventions, to not
interfere with the business of the Company in any manner and to preserve as
confidential and refrain from using the Company's Confidential Information. I
recognize that the unauthorized taking of any of the Company's trade secrets may
be a crime under Section 499(c) of the California Penal Code. I further
recognize that such unauthorized taking of the Company's property, including
without limitation, trade secrets, could also result in civil liability under
Civil Code Section 3426, and that a willful taking may result in an award
against me for the Company's attorney's fees and damages. I further agree that
in the event of termination of my employment with the Company (voluntary or
otherwise), I will protect the value of the Confidential Information and Company
Inventions and will prevent the misappropriation or disclosure thereof. I
further agree that for a period of one year following termination of my
employment with the Company, I shall not interfere with the business of the
Company or disrupt the Company's relationship with any of its employees or
customers by inducing or soliciting, or assisting others to induce or solicit,
either directly or indirectly, an employee to leave the Company's employ, a
consultant to sever that consultant's relationship with the Company or a
customer to cease doing business with the Company.
9. I will exercise reasonable care, consistent with good business judgment,
to preserve in good working order subject to reasonable wear and tear, and to
prevent loss on any instruments or accessories of the Company in my custody for
the purpose of making demonstrations, implementing trials, carrying out
development work, or otherwise conducting the business of the Company. I will
promptly surrender the same to the Company at the conclusion of my employment,
or if not surrendered, I will account to the Company to its reasonable
satisfaction as to the present location of all such instruments or accessories
and the business purpose for their placement at such location. At the conclusion
of my employment with the Company, I agree that no commission will be deemed to
be earned until the return of such instruments or accessories or my accounting
for the same to the Company's
2
reasonable satisfaction. The value of such instruments not returned will be
determined and deducted in determining final commission and bonus, if any.
10. I hereby acknowledge and agree that I have been or will be employed by
the Company in a position which could provide the opportunity for designing,
developing, improving, or inventing Confidential Information or Company
Inventions, among my other duties for the Company. I have carefully read this
entire Agreement and fully understand the same. I have been given the
opportunity to consult with independent legal counsel, of my own choosing and at
my own expense. I have listed on Schedule 1 hereof all unpatented, but
potentially patentable, ideas and inventions conceived prior to this employment
(and which have not been assigned to a former employer) and which are,
therefore, excluded from the scope of this Agreement. I acknowledge that the
Company has agreed to receive and hold this disclosure in confidence.
11. I hereby represent and warrant that there are no other agreements,
relationships or commitments to any other person or entity which conflict with
my obligations to the Company under this Agreement. I further agree that I will
not disclose to the Company, or use or induce the Company to use, any
proprietary information or trade secrets of others. I hereby represent and
warrant that I have returned all property and confidential information belonging
to all prior employers.
12. This Agreement will be binding upon my heirs, executors,
administrators, or other legal representatives or assigns and is for the benefit
of the Company and its successors and assigns. I understand and acknowledge that
because any breach of this Agreement by me may cause the Company irreparable
harm for which money is inadequate compensation, the Company will be entitled to
injunctive relief to enforce this Agreement in addition to damages and other
available remedies. I further agree that if any action is necessary to enforce
this Agreement, the prevailing party shall be entitled to recover its attorneys'
fees. I understand, acknowledge and agree that the protections set forth in this
Agreement are a material condition to my employment with and compensation by the
Company. I understand that: (a) This Agreement shall be governed by the laws of
the State of California without regard to principles of conflicts of laws; (b)
This Agreement and any confidentiality and non-disclosure agreement and
invention assignment agreement I signed while employed by any predecessor
company acquired by the Company, express the entire understanding of the Company
and the undersigned employee with respect to the subject matter hereof; (c) Each
and all of the several rights and remedies provided for in this Agreement shall
be cumulative; (d) No one right or remedy shall be exclusive of the others or of
any right or remedy allowed in law or in equity; (e) No waiver or indulgence by
the Company of any failure by me to keep or perform any promise or condition of
this Agreement shall be a waiver of any preceding or succeeding breach of the
same or any other promise or condition; (f) No waiver by the Company of any
right shall be construed as a waiver of any other right; (g) The Company shall
not be required to give notice to enforce strict adherence to all terms of this
Agreement.
13. In the case of any conflicting provision or provisions between this
Agreement and any previous confidentiality and non-disclosure agreement or
invention assignment agreement, the undersigned employee may have entered into
with a predecessor company acquired by the Company, this Agreement shall have
precedence.
14. If a court finds any provision of this Agreement to be invalid or
unenforceable as applied to any circumstance, I understand and intend that the
remainder of this Agreement and the application of such provision to other
circumstances shall be interpreted so as best to effect the intent of such
provision. I further agree that any such void or unenforceable provision of this
Agreement shall be replaced with a valid and enforceable provision which will
achieve, to the greatest extent possible, the economic, business and other
purposes of the void or unenforceable provision.
15. I understand and acknowledge that nothing contained in this Agreement
shall limit or otherwise alter either my ability or the Company's ability to
terminate my employment, with or without cause, with or without notice, at any
time. I further understand and acknowledge that my employment with the Company
shall be completely in the discretion of, and at the will of, the Company.
16. I agree that my employment with the Company requires my undivided
attention and effort. Therefore, during my employment with the Company, I will
not, without providing the Company reasonable prior notice and obtaining the
Company's prior express written consent, engage in any employment or business
other than for the Company, or assist in any manner any business competitive
with the business or future business plans of the Company.
I UNDERSTAND THIS AGREEMENT AFFECTS MY RIGHTS TO INNOVATIONS, INVENTIONS
AND IDEAS MADE DURING MY EMPLOYMENT AND RESTRICTS MY RIGHT TO DISCLOSE OR USE
THE COMPANY'S CONFIDENTIAL INFORMATION DURING OR SUBSEQUENT TO MY EMPLOYMENT. I
HAVE READ THIS AGREEMENT CAREFULLY AND UNDERSTAND ITS TERMS. I HAVE COMPLETELY
FILLED OUT THE LIST OF PRIOR INVENTIONS BELOW, IF ANY.
Signature /s/ David L. Schlotterbeck Date May 10, 2000
3
Print Name David L. Schlotterbeck
EMPLOYEE'S LIST OF PRIOR INVENTIONS
Employee Name: Date:
Invention Description Patent No. Date of Issue
--------------------- ---------- -------------
4
THE FOLLOWING SECTION APPLIES TO CALIFORNIA AND WASHINGTON EMPLOYEES
AND WASHINGTON RESIDENTS ONLY
WRITTEN NOTIFICATION TO EMPLOYEE
In accordance with California Labor Code Section 2872 and Revised Code of
Washington Section 49.44.140, you are hereby notified that your Employee
Confidentiality and Invention Assignment Agreement does not require you to
assign to the Company any invention for which no equipment, supplies, facility,
or trade secret information of the Company was used and which was developed
entirely on your own time, and which does not relate to the business of the
Company or to the Company's actual or demonstrably anticipated research or
development, or which does not result from any work performed by you for the
Company. However, you are required to disclose all inventions you develop during
your employment by the Company, whether or not during regular working hours.
THE FOLLOWING IS THE TEXT OF CALIFORNIA LABOR CODE SECTION 2870:
"(a) Any provision in an employment agreement which provides that an
employee shall assign, or offer to assign, any of his or her rights in an
invention to his or her employer shall not apply to an invention that the
employee developed entirely on his or her own time without using the employer's
equipment, supplies, facilities, or trade secret information except for those
inventions that either:
(1) Relate at the time of conception or reduction to practice of the
invention to the employer's business, or actual or demonstrably
anticipated research or development of the employer; or
(2) Result from any work performed by the employee for the employer.
(b) To the extent a provision in an employment agreement purports to
require an employee to assign an invention otherwise excluded from being
required to be assigned under subdivision (a), the provision is against the
public policy of this state and is unenforceable."
THE FOLLOWING IS THE TEXT OF THE REVISED CODE OF WASHINGTON SECTION
49.44.140:
"A provision in an employment agreement which provides that an employee
shall assign or offer to assign any of the employee's rights in an invention to
the employer does not apply to an invention for which no equipment, supplies,
facilities, or trade secret information of the employer was used and which was
developed entirely on the employee's own time, unless
(a) the invention relates (i) directly to the business of the employer, or
(ii) to the employer's actual or demonstrably anticipated research or
development, or
(b) the invention results from any work performed by the employee for the
employer. Any provision which purports to apply to such an invention is to that
extent against the public policy of this state and is to that extent void and
unenforceable."
I HEREBY ACKNOWLEDGE RECEIPT OF THIS WRITTEN NOTIFICATION CONTAINING
CALIFORNIA LABOR CODE SECTION 2870 AND REVISED CODE OF WASHINGTON SECTION
49.44.140.
Signature /s/ David L. Schlotterbeck Date May 10, 2000
--------------------------- ---------------------------------
Print Name David L. Schlotterbeck
--------------------------
5
Exhibit 10.52
SUMMARY SHEET
COMPENSATION AND BENEFITS FOR NAMED EXECUTIVE OFFICERS AND
CERTAIN OTHER EXECUTIVE OFFICERS
Effective September 9, 2005
The employment of Robert D. Walter, George L. Fotiades and Ronald K.
Labrum with Cardinal Health, Inc. (the "Company") is governed by employment
agreements dated February 1, 2004, February 1, 2004 (as amended February 4,
2005) and November 5, 2003, respectively, which agreements outline certain
elements of each executive officer's compensation and benefits. David L.
Schlotterbeck, Anthony J. Rucci and Jeffrey W. Henderson do not have employment
agreements with the Company, but certain of Messrs. Schlotterbeck's and
Henderson's compensation arrangements are set forth in a retention agreement
dated August 31, 2004 and an offer letter dated April 13, 2005, respectively.
Each executive officer is a party to equity incentive award agreements with the
Company. In addition, Mr. Walter's employment agreement contains specific
provisions regarding equity incentive awards. The following are additional
details concerning compensation and benefits for the above executive officers.
CURRENT CURRENT
NAME AND ANNUAL ANNUAL CASH RETIREMENT OTHER GENERAL
PRINCIPAL POSITION BASE SALARY INCENTIVE TARGET BENEFITS BENEFITS AND PERQUISITES (1)
----------------------------- ----------- ---------------- ------------------------------- -------------------------------
Robert D. Walter $1,111,396 300% of annual Participation in the Company's Health, welfare and stock
Chairman and Chief Executive base salary 401(k) Savings Plan and purchase benefits on same terms
Officer Deferred Compensation Plan on generally available to Company
same terms offered to all plan employees.
participants, including Company
match and annual contribution. Coverage under the Company's
D&O liability insurance policy.
Personal use of Company plane
(including tax gross-up).(2)
George L. Fotiades $ 790,000 140% of annual Participation in the Company's Health, welfare and stock
President and Chief base salary 401(k) Savings Plan and purchase benefits on same terms
Operating Officer Deferred Compensation Plan on generally available to Company
same terms offered to all plan employees.
participants, including Company
match and annual contribution. Coverage under the Company's
D&O liability insurance policy.
Participation in the R.P. Personal use of Company plane
Scherer Corporation Employees' (including tax gross-up as
Retirement Income Plan (Plan approved by Human Resources and
frozen as of December 31, Compensation Committee).
2002).
Participation in the
Supplemental Benefit Plan for
Key Employees of R.P. Scherer
Corporation (Plan frozen as of
December 31, 2001).
Ronald K. Labrum $ 575,000 100% of annual Participation in the Company's Health, welfare and stock
Chairman and Chief Executive base salary 401(k) Savings Plan and purchase benefits on same terms
Officer - Integrated Deferred Compensation Plan on generally available to Company
Provider Solutions and same terms offered to all plan employees.
Cardinal Health International participants, including Company
match and annual contribution. Coverage under the Company's
D&O liability insurance policy.
Personal use of Company plane
as authorized by the CEO or
COO (including tax gross-up as
approved by Human Resources and
Compensation Committee).
(1) See also the Summary Compensation Table in the Company's latest annual
proxy statement for disclosure of other perquisites provided to certain of
the executive officers.
(2) For security reasons, the Company's Board-approved policy requires the
Chairman and Chief Executive Officer to use Company aircraft for personal
travel.
CURRENT CURRENT
NAME AND ANNUAL ANNUAL CASH RETIREMENT OTHER GENERAL
PRINCIPAL POSITION BASE SALARY INCENTIVE TARGET BENEFITS BENEFITS AND PERQUISITES (1)
----------------------------- ----------- ---------------- ------------------------------- -------------------------------
David L. Schlotterbeck $ 580,000 100% of annual Participation in the Company's Health, welfare and stock
Chairman and Chief base salary 401(k) Savings Plan and purchase benefits on same terms
Executive Officer - Deferred Compensation Plan on generally available to Company
Clinical Technologies and same terms offered to all plan employees.
Services participants, including Company
match and annual contribution. Coverage under the Company's
D&O liability insurance policy.
Personal use of Company plane
as authorized by the CEO or
COO (including tax gross-up as
approved by Human Resources and
Compensation Committee).
Anthony J. Rucci $ 500,000 90% of annual Participation in the Company's Health, welfare and stock
Executive Vice President and base salary 401(k) Savings Plan and purchase benefits on same terms
President of Strategic Deferred Compensation Plan on generally available to Company
Corporate Resources same terms offered to all plan employees.
participants, including Company
match and annual contribution. Coverage under the Company's
D&O liability insurance policy.
Personal use of Company plane
as authorized by the CEO or
COO (including tax gross-up as
approved by Human Resources and
Compensation Committee).
Jeffrey W. Henderson $ 550,000 100% of annual Participation in the Company's Health, welfare and stock
Executive Vice President and base salary 401(k) Savings Plan and purchase benefits on same terms
Chief Financial Officer Deferred Compensation Plan on generally available to Company
same terms offered to all plan employees.
participants, including Company
match and annual contribution. Coverage under the Company's
D&O liability insurance policy.
Personal use of Company plane
as authorized by the CEO or
COO (including tax gross-up as
approved by Human Resources and
Compensation Committee).
.
.
.
Exhibit 21.01
SUBSIDIARIES OF THE REGISTRANT
AS AT 06/30/05
STATE / JURISDICTION
SUBSIDIARY NAME OF INCORPORATION
--------------- ----------------------
Abilene Nuclear, LLC Delaware
- 80% Cardinal Health 414, Inc.
Academy of Managed Care Medicine, L.L.C. Delaware
ALARIS Medical Espana, S.L. Spain
ALARIS Medical Holland B.V. Netherlands
ALARIS Medical France S.A. France
ALARIS Medical Norway A/S Norway
ALARIS Medical Italia S.P.A. Italy
ALARIS Medical New Zealand Limited New Zealand
ALARIS Medical Australia Pty Limited Australia
ALARIS Medical Nordic AB Sweden
ALARIS Medical Systems Deutschland, GmbH Germany
ALARIS Medical Canada Ltd. Canada
ALARIS Medical Systems, S.A. Proprietary Limited South Africa
ALARIS Medical Systems Foreign Sales Corporation Barbados
ALARIS Medical Luxembourg I S.a.r.l. Luxembourg
ALARIS Medical Luxembourg II S.a.r.l. Luxembourg
ALARIS Medical Luxembourg I S.a.r.l., S.C.S. Luxembourg
ALARIS Medical 1 (Suisse), S.a.r.l. Switzerland
ALARIS Medical 2 (Suisse), S.a.r.l. Switzerland
ALARIS Medical Cayman Islands Cayman Islands
Alcon - Building Branch Puerto Rico
Allcaps Weichgelatinkapseln GmbH & Co. KG Germany
Allcaps Weichgelatinkapseln Verwaltungs GmbH Germany
Allegiance (BVI) Holdings Co. Ltd. British Virgin Islands
Allegiance Corporation Delaware
Allegiance Healthcare (Labuan) Pte. Ltd. Malaysia
Allegiance Healthcare Deutschland Holding GmbH Germany
Allegiance Healthcare Distribution GmbH Austria
Allegiance Healthcare Holding B.V. Netherlands
Allegiance Healthcare International GmbH Austria
Allegiance K. K. Japan
Allegiance Labuan Holdings Pte. Ltd. Malaysia
API (Suppliers) Limited United Kingdom
Arclight Systems LLC Delaware
Armand Scott, LLC Delaware
Aurum Pharmaceuticals Limited United Kingdom
Bauer Branch Dominican Republic
Beckloff Associates, Inc. Kansas
C. International, Inc. Ohio
Cardal II, LLC Delaware
Cardal, Inc. Ohio
Cardinal Distribution Holding Corporation - I Nevada
Cardinal Distribution Holding Corporation - II Nevada
Cardinal Health (Bermuda) 224 Ltd. Bermuda
Cardinal Health 100, Inc. Indiana
(f/k/a Bindley Western Industries, Inc.)
Cardinal Health 101, Inc. Delaware
(f/k/a Cardinal Health Provider Pharmacy Services,
Inc.)
Cardinal Health 102, Inc. Ohio
(f/k/a Cardinal Health Staffing Network, Inc.)
Cardinal Health 104 LP Ohio
(f/k/a Cardinal Distribution LP)
Cardinal Health 105, Inc. Ohio
(f/k/a CORD Logistics, Inc.)
Cardinal Health 107, Inc. Ohio
(f/k/a National Pharmpak Services, Inc.)
Cardinal Health 108, Inc. Tennessee
(f/k/a National Specialty Services, Inc.)
Cardinal Health 109, Inc. Texas
(f/k/a Owen Healthcare, Inc.)
Cardinal Health 110, Inc. Delaware
(f/k/a Whitmire Distribution Corporation)
Cardinal Health 111, LLC Delaware
Cardinal Health 112, LLC Delaware
Cardinal Health 2, Inc. Nevada
(f/k/a The Griffin Group, Inc.)
Cardinal Health 200, Inc. Delaware
(f/k/a Allegiance Healthcare Corporation)
Cardinal Health 201, Inc. Delaware
(f/k/a Allegiance Healthcare International, Inc.)
Cardinal Health 222 (Thailand) Ltd. Thailand
(f/k/a Allegiance Healthcare (Thailand) Ltd.)
Cardinal Health 3, Inc. Nevada
(f/k/a Red Wing Data Corporation)
Cardinal Health 301, Inc. Delaware
(f/k/a Pyxis Corporation)
Cardinal Health 302, LLC Delaware
Cardinal Health 303, Inc. Delaware
(f/k/a ALARIS Medical Systems, Inc.)
Cardinal Health 304, LLC Delaware
Cardinal Health 400, Inc. Illinois
(f/k/a Automatic Liquid Packaging, Inc.)
Cardinal Health 406, LLC Delaware
Cardinal Health 409, Inc. Delaware
(f/k/a R.P. Scherer Corporation)
Cardinal Health 411, Inc. Ohio
(f/k/a RedKey, Inc.)
Cardinal Health 414, Inc. Delaware
(f/k/a Syncor International Corporation)
Cardinal Health 416, Inc. Delaware
(f/k/a PCI Services II, Inc.)
Cardinal Health 417, Inc. Delaware
(f/k/a PCI Services III, Inc.)
Cardinal Health 418, Inc. Delaware
(f/k/a Syncor Pharmaceuticals, Inc.)
Cardinal Health 420, LLC Delaware
(f/k/a Syncor Advanced Isotopes, LLC)
Cardinal Health 421 Limited Partnership Scotland
Cardinal Health 421, Inc. Delaware
(f/k/a RPS Technical Services, Inc.)
Cardinal Health 5, LLC Delaware
Cardinal Health 6, Inc. Nevada
(f/k/a Physicians Purchasing, Inc.)
Cardinal Health Argentina 400 S.A.I.C. Argentina
(f/k/a R.P. Scherer Argentina S.A.I.C.)
Cardinal Health Australia 200 Pty Ltd Australia
(f/k/a Allegiance Healthcare Pty Ltd)
Cardinal Health Australia 300 Pty Ltd Australia
(f/k/a Axiom Healthcare Services Pty. Ltd.)
Cardinal Health Australia 401 Pty Ltd Australia
(f/k/a R.P. Scherer Holdings Pty. Ltd.)
Cardinal Health Belgium 202 S.P.R.L. Belgium
(f/k/a Allegiance S.P.R.L.)
Cardinal Health Brasil 402 Ltda. Brazil
(f/k/a R.P. Scherer do Brasil Encapsulacoes, Ltda.)
Cardinal Health Canada 204, Inc. Canada
(f/k/a Allegiance Healthcare Canada Inc.)
Cardinal Health Canada 301, Inc. Canada
(f/k/a H.E.N. Inc.)
Cardinal Health Canada 302, Inc. Canada
(f/k/a Pyxis Healthcare Systems, Inc.)
Cardinal Health Canada 403, Inc. Canada
(f/k/a R.P. Scherer Canada Inc.)
Cardinal Health Capital Corporation Ohio
Cardinal Health Corporate Solutions, LLC Nevada
(f/k/a Cardinal Health 4, LLC)
Cardinal Health D.R. 203 Ltd. Bermuda
(f/k/a Allegiance International Manufacturing (Bermuda)
Ltd.)
Cardinal Health Finance United Kingdom
Cardinal Health France 205 S.A.S. France
(f/k/a Allegiance Sante S.A.S.)
Cardinal Health France 404 S.A. France
(f/k/a R.P. Scherer S.A.)
- Cardinal Health 409, Inc. (f/k/a R.P. Scherer
Corporation) - 684,664 shares - 99.7083%
- F&F Holding GmbH - 1,000 shares - 0.1456%
Cardinal Health France 428 S.A.S. France
(f/k/a Societe Financiere Osny S.A.S.)
Cardinal Health France 429 S.A.S. France
(f/k/a LCO Sante S.A.S.)
Cardinal Health France 430 S.A.S. France
(f/k/a Federa France S.A.S.)
Cardinal Health France 431 S.A.S. France
(f/k/a Federa Limoges S.A.S.)
Cardinal Health Funding, LLC Nevada
Cardinal Health GbR Germany
Cardinal Health Germany 206 GmbH Germany
(f/k/a Allegiance Healthcare Deutschland GmbH)
Cardinal Health Germany 405 GmbH Germany
(f/k/a Cardinal Health Germany GmbH)
Cardinal Health Germany Holdings GmbH Germany
Cardinal Health (Gibraltar) 320 Limited Gibraltar
Cardinal Health Holding GmbH Germany
Cardinal Health Holding International, Inc. New Jersey
Cardinal Health Holding Pty Ltd Australia
Cardinal Health Holdings Limited United Kingdom
Cardinal Health International Ventures, Ltd. Barbados
Cardinal Health Ireland 406 Ltd. Ireland
(f/k/a Cardinal Health Technologies Ltd.)
Cardinal Health Ireland 419 Limited Ireland
Cardinal Health Ireland 422 Limited Ireland
Cardinal Health Italy 208 S.r.l. Italy
(f/k/a Allegiance Medica S.R.L.)
Cardinal Health Italy 407 S.p.A. Italy
(f/k/a R.P. Scherer S.p.A.)
Cardinal Health Japan 408 K.K. Japan
(f/k/a R.P. Scherer K.K.)
Cardinal Health Lease Funding 2002A, LLC Delaware
Cardinal Health Lease Funding 2002AQ, LLC Delaware
Cardinal Health Lease Funding 2003A, LLC Delaware
Cardinal Health Lease Funding 2003AQ, LLC Delaware
Cardinal Health Lease Funding 2003B, LLC Delaware
Cardinal Health Lease Funding 2003BQ, LLC Delaware
Cardinal Health Lease Funding 2004A, LLC Delaware
Cardinal Health Lease Funding 2004AQ, LLC Delaware
Cardinal Health Luxembourg 420 S.a.r.l. Luxembourg
Cardinal Health MPB, Inc. Missouri
(f/k/a Managed Pharmacy Benefits, Inc.)
Cardinal Health Malaysia 211 Sdn. Bhd. Malaysia
(f/k/a Allegiance Healthcare Sdn. Bhd.)
Cardinal Health Malta 212 Limited Malta
(f/k/a Eurovac Limited)
Cardinal Health Mexico 213 S.A. de C.V. Mexico
(f/k/a Allegiance De Mexico, S.A. de C.V.)
Cardinal Health N.Z. 217 Limited New Zealand
[f/k/a Cardinal Health (N.Z.) Limited]
Cardinal Health Netherlands 214 B.V. Netherlands
(f/k/a Allegiance B.V.)
Cardinal Health Netherlands Financing C.V. Netherlands
Cardinal Health Netherlands Holding B.V. Netherlands
Cardinal Health P.R. 218, Inc. Puerto Rico
(f/k/a Allegiance PRO, Inc.)
Cardinal Health P.R. 227, Inc. Puerto Rico
Cardinal Health P.R. 409 B.V. The Netherlands
(f/k/a Cardinal Health Manufacturing Services B. V.)
Cardinal Health P.R. 410, Inc. Puerto Rico
(f/k/a PCI Services I, Inc.)
Cardinal Health P.R. 436, Inc. Puerto Rico
Cardinal Health PTS, LLC Delaware
Cardinal Health Singapore 225 Pte. Ltd. Singapore
Cardinal Health Singapore 304 Singapore
Cardinal Health Singapore 423 Pte. Ltd. Singapore
(f/k/a Cardinal Health Singapore 303 Pte. Ltd.)
Cardinal Health Spain 219 S.L. Spain
(f/k/a Allegiance S.L.)
Cardinal Health Sweden 220 AB Sweden
(f/k/a Allegiance AB)
Cardinal Health Switzerland 221 GmbH Switzerland
(f/k/a Allegiance Healthcare GmbH)
Cardinal Health Switzerland 412 GmbH Switzerland
(f/k/a Cardinal Health (Europe) GmbH)
Cardinal Health Switzerland 413 AG Switzerland
(f/k/a R.P. Scherer (Europe) AG)
Cardinal Health Systems, Inc. Ohio
Cardinal Health Technologies Switzerland GmbH Switzerland
Cardinal Health Technologies, LLC Nevada
Cardinal Health Trading (Shanghai) Co. Ltd. China
Cardinal Health U.K. 100 Limited United Kingdom
(f/k/a IPD Group Limited)
Cardinal Health U.K. 101 Limited United Kingdom
(f/k/a Intercare Pharmaceuticals Distribution Limited)
Cardinal Health U.K. 223 Limited United Kingdom
(f/k/a Allegiance Healthcare Limited)
Cardinal Health U.K. 305 Limited United Kingdom
(f/k/a ALARIS Medical U.K. Limited)
Cardinal Health U.K. 306 Limited United Kingdom
Cardinal Health U.K. 414 Limited United Kingdom
(f/k/a R. P. Scherer Limited)
Cardinal Health U.K. 415 Limited United Kingdom
(f/k/a R.P. Scherer Holdings Limited)
Cardinal Health U.K. 416 Limited United Kingdom
(f/k/a Scherer DDS Limited)
Cardinal Health U.K. 417 Limited United Kingdom
(f/k/a Unipack, Ltd.)
Cardinal Health U.K. 418 Limited United Kingdom
Cardinal Health U.K. 425 Limited United Kingdom
(f/k/a Herd Mundy Richardson Limited)
Cardinal Health U.K. 432 Limited United Kingdom
(f/k/a The Intercare Group Limited)
Cardinal Health U.K. 433 Limited United Kingdom
(f/k/a Macarthy Group Limited)
Cardinal Health U.K. 434 Limited United Kingdom
Cardinal Health U.K. 435 Limited United Kingdom
(f/k/a Herd Mundy Richardson (Holdings) Limited)
Cardinal.com Holdings, Inc. Nevada
Cascade Development, Inc. Nevada
Caseview (P.L.) Limited United Kingdom
CCB, Inc. Iowa
CDI Investments, Inc. Delaware
Centralia Pharmacy, Inc. Illinois
Centricity, LLC Delaware
(f/k/a Boron LePore, Inc.)
Cirmex de Chihuahua S.A. de C.V. Mexico
Cirpro de Delicias S.A. de C.V. Mexico
CMI Net, Inc. Delaware
Comprehensive Medical Imaging--Anaheim Hills, Inc. Delaware
Comprehensive Medical Imaging--Apple Valley, Inc. Delaware
Comprehensive Medical Imaging--Boynton Beach, Inc. Delaware
Comprehensive Medical Imaging--Downey, Inc. Delaware
Comprehensive Medical Imaging--Encino, Inc. Delaware
Comprehensive Medical Imaging--Fort Lauderdale, Inc. Delaware
Comprehensive Medical Imaging--Hesperia, Inc. Delaware
Comprehensive Medical Imaging--Huntington Beach, Inc. Delaware
Comprehensive Medical Imaging--Palm Beach Gardens, Inc. Delaware
Comprehensive Medical Imaging--Palm Springs, Inc. Delaware
Comprehensive Medical Imaging--Rancho Cucamonga, Inc. Delaware
Comprehensive Medical Imaging--Santa Maria, Inc. Delaware
Comprehensive Medical Imaging--Sherman Oaks, Inc. Delaware
Comprehensive Medical Imaging--Tempe, Inc. Delaware
Comprehensive Medical Imaging--Van Nuys, Inc. Delaware
Comprehensive Medical Imaging--Victorville, Inc. Delaware
Comprehensive Medical Imaging--Westlake Village, Inc. Delaware
Comprehensive OPEN MRI - Carmichael, Inc. Delaware
Comprehensive OPEN MRI--Folsom, Inc. Delaware
Comprehensive OPEN MRI--Fullerton, Inc. Delaware
Comprehensive OPEN MRI--Laguna Hills, Inc. Delaware
Comprehensive OPEN MRI--Sacramento, Inc. Delaware
Consumer2Patient, LLC. Delaware
Converters Branch Dominican Republic
Convertors de Mexico S.A. de C.V. Mexico
CR Medicap, Inc. Iowa
Craig Generics Limited United Kingdom
Crossject S.A. France
Cytokine Pharmasciences Delaware
Daniels Pharmaceuticals Limited United Kingdom
Desert PET, LLC California
Diagnostic Purchasing Group, Inc. Delaware
Dover Communications, LLC Delaware
(f/k/a BLP-Dover Acquisition Corp.)
DuQuoin Pharmacy, Inc. Illinois
Dutch American Manufacturers (D.A.M.) B.V. Netherlands
East Iowa Pharmacies, Inc. Iowa
Eldon Laboratories Limited United Kingdom
Ellipticare, LLC Delaware
EPIC Insurance Company Vermont
Eurochem Limited United Kingdom
European Pharmaceuticals Group Ltd. United Kingdom
Europharm of Worthing Limited United Kingdom
F&F Holding GmbH Germany
Federa S.A. Belgium
Freeman Pharmaceuticals Limited United Kingdom
Glacier Guaranty Corporation Vermont
Glamorgan Pharmaceuticals Limited United Kingdom
Global Healthcare Exchange, LLC Delaware
Grand Avenue Pharmacy, Inc. Iowa
Griffin Capital, LLC Nevada
Griffin Group Document Management Services, Inc. Nevada
(f/k/a Supplyline Holdings, Inc.)
Homecare (North-West) Limited United Kingdom
IMI Diagnostic Center, Inc. Delaware
IMI of Boca Raton, Inc. Delaware
IMI of Miami, Inc. Delaware
IMI of North Miami Beach, Inc. Delaware
IMI-NET, Inc. Delaware
Impharm Nationwide Limited United Kingdom
InGel Technologies Ltd. United Kingdom
Inland Empire Regional PET Center, LLC California
InteCardia-Tennessee East Catheterization, LLC North Carolina
- 75% Syncor Cardiology Services, LLC
InteCardia-Tennessee East Diagnostic, LLC North Carolina
Intercare Holdings Limited United Kingdom
Intercare Investments Limited United Kingdom
Intercare Properties Plc United Kingdom
International Capsule Company S.r.l. Italy
Iowa Falls Pharmacy, Inc. Iowa
IVAC Overseas Holdings, L.P. Delaware
(f/k/a IVAC Overseas Holdings, Inc.)
JRG, Ltd. Iowa
Killilea Development Company, Ltd. Ohio
Lake Charles Pharmaceutical and Medical Equipment Louisiana
Supply Company, L.L.C.
- A Louisiana limited liability company formed by
Owen Shared Services, Inc. and Lake Charles
Memorial Hospital, Inc.
Leader Drugstores, Inc. Delaware
Liberty Communications Network, LLC Delaware
(f/k/a BLP-Liberty Acquisition Corp.)
Macarthy Group Trustees Limited United Kingdom
Macarthy Limited United Kingdom
Macarthy's Laboratories Limited United Kingdom
Martindale Pharmaceuticals Limited United Kingdom
Medcon S.A. Luxembourg
Medesta Associates, LLC Delaware
Medical Diagnostic Leasing, Inc. Delaware
Medical Education Systems, LLC Delaware
Medical Media Communications, LLC Delaware
Medicap Pharmacies Incorporated Iowa
Medicine Shoppe Capital Corporation Nevada
Medicine Shoppe International, Inc. Delaware
Medicine Shoppe Internet, Inc. Missouri
MediQual Systems, Inc. Delaware
Midland Pharmacies, Inc. Iowa
Moresville, Limited United Kingdom
MRI Equipment Partners, Ltd. Texas
- 59.16% Comprehensive Medical Imaging, Inc.
Multi-Medica S.A. Belgium
Multipharm Limited United Kingdom
Nationwide Ostomy Supplies Limited United Kingdom
NewHealthCo LLC Delaware
Oldimp B.V. Netherlands
(f/k/a International Medical Products B.V.)
OnPointe Medical Communications, LLC Delaware
Owen Shared Services, Inc. Texas
PCI Holdings (UK) Co. United Kingdom
Pharmaceutical and Diagnostic Services, Inc. Utah
- 50% Cardinal Health 414, Inc.
Pharmacy Operations of New York, Inc. New York
Pharmacy Operations, Inc. Delaware
Pharmapar S.A. Belgium
Phillipi Holdings, Inc. Ohio
Physicians Purchasing, Inc. Nevada
Pinnacle Intellectual Property Services International, Nevada
Inc.
Pinnacle Intellectual Property Services, Inc. Nevada
PlastiMedical S.p.A. Italy
Practicome Solutions, LLC Delaware
Productos Urologos de Mexico S.A. de C.V. Mexico
Quiroproductos de Cuauhtemoc S.A. de C.V. Mexico
R.P. Scherer (Spain) S.A. Spain
R.P. Scherer DDS B.V. Netherlands
R.P. Scherer Egypt Egypt
R.P. Scherer GmbH & Co. KG Germany
- F & F Holdings GmbH - 50.94%
- R.P. Scherer Verwaltungs GmbH - 0.11%
R.P. Scherer Holdings II Limited United Kingdom
R.P. Scherer Technologies, Inc. Nevada
R.P. Scherer Verwaltungs GmbH Germany
- F & F Holdings GmbH - 51%
Ransdell Surgical, Inc. Kentucky
RBP Pharma S.A. France
Respirare, LLC Delaware
Riverside MRI, JV Texas
RxealTIME, Inc. Nevada
RxPedite, LLC Ohio
Sierra Radiopharmacy, LLC Nevada
- 51% Cardinal Health 414, Inc.
Simolo (GL) Limited United Kingdom
Sistemas Medicos ALARIS, S.A. de C.V. Mexico
Source Medical Corporation Canada
- Allegiance Healthcare Canada Inc. controls with
- 50% of common shares & 100% of preferred share
(1 share)
SRx, Inc. Iowa
STI Deutschland GmbH Surgical Technologies Germany
International
Strategic Implications International, LLC Delaware
Supplyline Technologies Limited Ireland
Surgical Technologies B.V. Netherlands
Surgi-Tech Europa Divisione Surgi-Tech Italia SRL Italy
Syncor Belgium SPRL Belgium
Syncor Cardiology Services, LLC Delaware
Syncor Diagnostics Dallas, LLC Texas
Syncor Diagnostics Encino, LLC California
Syncor Diagnostics Fullerton LLC California
Syncor Diagnostics Laguna Hills LLC California
Syncor Diagnostics Plano, LLC Texas
Syncor Italy s.r.l. Italy
Syncor Midland, Inc. Texas
Toledo Pharmacy Co. Iowa
Top Shot Publishers Limited Ireland
Venture Laminate Limited Ireland
Venture Packaging Limited Ireland
Virginia Imaging Center, LLC Virginia
- 90% Syncor Cardiology Services, LLC
West Texas Nuclear Pharmacy Partners Texas
- Syncor Midland, Inc. (50%)
Wholesale (PI) Limited United Kingdom
Yorkshire Pharmacy, Inc. Nebraska
Exhibit 23.01
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration
Statements:
(1) Registration Statements on Form S-3 (No. 333-101907, No. 333-62944, No.
333-24483, No. 333-46482, No. 33-62198 and No. 33-57223) of Cardinal
Health, Inc.,
(2) Registration Statements on Form S-4 (No. 333-62938 and No. 333-74761) of
Cardinal Health, Inc., and
of our reports dated September 9, 2005, with respect to the consolidated
financial statements and schedule of Cardinal Health, Inc., Cardinal Health,
Inc. management's assessment of the effectiveness of internal control over
financial reporting, and the effectiveness of internal control over financial
reporting of Cardinal Health, Inc., included in this Annual Report (Form 10-K)
for the fiscal year ended June 30, 2005.
/s/ Ernst & Young LLP
Columbus, Ohio
September 12, 2005
Exhibit 31.01
I, Robert D. Walter, certify that:
1. I have reviewed this Form 10-K of Cardinal Health, Inc.;
2. Based on my knowledge, this report does not contain any untrue
statement of a material fact or omit to state a material fact
necessary to make the statements made, in light of the circumstances
under which such statements were made, not misleading with respect to
the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material
respects the financial condition, results of operations and cash flows
of the registrant as of, and for, the periods presented in this
report;
4. The registrant's other certifying officer(s) and I are responsible for
establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal
control over financial reporting (as defined in Exchange Act
Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a. Designed such disclosure controls and procedures, or caused such
disclosure controls and procedures to be designed under our
supervision, to ensure that material information relating to the
registrant, including its consolidated subsidiaries, is made
known to us by others within those entities, particularly during
the period in which this report is being prepared;
b. Designed such internal control over financial reporting, or
caused such internal control over financial reporting to be
designed under our supervision, to provide reasonable assurance
regarding the reliability of financial reporting and the
preparation of financial statements for external purposes in
accordance with generally accepted accounting principles;
c. Evaluated the effectiveness of the registrant's disclosure
controls and procedures and presented in this report our
conclusions about the effectiveness of the disclosure controls
and procedures, as of the end of the period covered by this
report based on such evaluation; and
d. Disclosed in this report any change in the registrant's internal
control over financial reporting that occurred during the
registrant's most recent fiscal quarter (the registrant's fourth
fiscal quarter in the case of an annual report) that has
materially affected, or is reasonably likely to materially
affect, the registrant's internal control over financial
reporting; and
5. The registrant's other certifying officer(s) and I have disclosed,
based on our most recent evaluation of internal control over financial
reporting, to the registrant's auditors and the audit committee of the
registrant's board of directors (or persons performing the equivalent
functions):
a. All significant deficiencies and material weaknesses in the
design or operation of internal control over financial reporting
which are reasonably likely to adversely affect the registrant's
ability to record, process, summarize and report financial
information; and
b. Any fraud, whether or not material, that involves management or
other employees who have a significant role in the registrant's
internal control over financial reporting.
Dated: September 12, 2005
/s/ Robert D. Walter
----------------------------------------
Robert D. Walter
Chairman and Chief Executive Officer
Exhibit 31.02
I, Jeffrey W. Henderson, certify that:
1. I have reviewed this Form 10-K of Cardinal Health, Inc.;
2. Based on my knowledge, this report does not contain any untrue
statement of a material fact or omit to state a material fact
necessary to make the statements made, in light of the circumstances
under which such statements were made, not misleading with respect to
the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material
respects the financial condition, results of operations and cash flows
of the registrant as of, and for, the periods presented in this
report;
4. The registrant's other certifying officer(s) and I are responsible for
establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal
control over financial reporting (as defined in Exchange Act Rules
13a-15(f) and 15d-15(f)) for the registrant and have:
a. Designed such disclosure controls and procedures, or caused such
disclosure controls and procedures to be designed under our
supervision, to ensure that material information relating to the
registrant, including its consolidated subsidiaries, is made
known to us by others within those entities, particularly during
the period in which this report is being prepared;
b. Designed such internal control over financial reporting, or
caused such internal control over financial reporting to be
designed under our supervision, to provide reasonable assurance
regarding the reliability of financial reporting and the
preparation of financial statements for external purposes in
accordance with generally accepted accounting principles;
c. Evaluated the effectiveness of the registrant's disclosure
controls and procedures and presented in this report our
conclusions about the effectiveness of the disclosure controls
and procedures, as of the end of the period covered by this
report based on such evaluation; and
d. Disclosed in this report any change in the registrant's internal
control over financial reporting that occurred during the
registrant's most recent fiscal quarter (the registrant's fourth
fiscal quarter in the case of an annual report) that has
materially affected, or is reasonably likely to materially
affect, the registrant's internal control over financial
reporting; and
5. The registrant's other certifying officer(s) and I have disclosed,
based on our most recent evaluation of internal control over financial
reporting, to the registrant's auditors and the audit committee of the
registrant's board of directors (or persons performing the equivalent
functions):
a. All significant deficiencies and material weaknesses in the
design or operation of internal control over financial reporting
which are reasonably likely to adversely affect the registrant's
ability to record, process, summarize and report financial
information; and
b. Any fraud, whether or not material, that involves management or
other employees who have a significant role in the registrant's
internal control over financial reporting.
Dated: September 12, 2005
/s/ Jeffrey W. Henderson
-------------------------------------
Jeffrey W. Henderson
Executive Vice President and
Chief Financial Officer
Exhibit 32.01
CERTIFICATION BY THE CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Robert D. Walter, Chairman and Chief Executive Officer of Cardinal
Health, Inc. (the "Company"), certify, pursuant to 18 U.S.C. Section 1350, that:
(1) the Annual Report on Form 10-K for the fiscal year ended June 30, 2005
containing the financial statements of the Company (the "Periodic Report"),
which this statement accompanies, fully complies with the requirements of
Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C.
78m or 78o(d)), and
(2) the information contained in the Periodic Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company.
Dated: September 12, 2005
/s/ Robert D. Walter
----------------------------------------
Robert D. Walter
Chairman and Chief Executive Officer
Exhibit 32.02
CERTIFICATION BY THE CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Jeffrey W. Henderson, Executive Vice President and Chief Financial
Officer of Cardinal Health, Inc. (the "Company"), certify, pursuant to 18 U.S.C.
Section 1350, that:
(1) the Annual Report on Form 10-K for the fiscal year ended June 30, 2005
containing the financial statements of the Company (the "Periodic Report"),
which this statement accompanies, fully complies with the requirements of
Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C.
78m or 78o(d)), and
(2) the information contained in the Periodic Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company.
Dated: September 12, 2005
/s/ Jeffrey W. Henderson
----------------------------------------
Jeffrey W. Henderson
Executive Vice President and
Chief Financial Officer
Exhibit 99.01
The Private Securities Litigation Reform Act of 1995, as amended (the "Act"),
provides a "safe harbor" for "forward-looking statements" (as defined in the
Act). The Company's filings with the Securities and Exchange Commission (the
"SEC"), including its Annual Report on Form 10-K, Summary Annual Report to
Shareholders, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K
(along with any exhibits to such filings as well as any amendments to such
filings), press releases, other written or oral statements made by or on behalf
of the Company, may include, refer to or incorporate by reference
forward-looking statements that reflect the Company's current view (as of the
date such forward-looking statement is made) with respect to future events,
prospects, projections and/or financial performance. These forward-looking
statements are subject to various risks and uncertainties that could cause
actual results to differ materially from those contemplated, projected,
anticipated or implied by these forward-looking statements. These risks and
uncertainties include, but are not limited to:
- uncertainties relating to general economic, political, business,
industry, regulatory and market conditions;
- the loss of one or more key customer or supplier relationships, such
as pharmaceutical and medical/surgical manufacturers for which
alternative supplies may not be available or easily replaceable, or
unfavorable changes to the terms of those relationships, or changes
in customer mix;
- changes in manufacturers' pricing, selling, inventory, distribution
or supply policies or practices, including policies concerning price
inflation or deflation;
- uncertainties related to negotiation of distribution service
agreements entered into in connection with the Company's
Pharmaceutical Distribution business model transition with respect
to how the Company is compensated for the logistical, capital and
administrative services that it provides to branded pharmaceutical
manufacturers;
- the Pharmaceutical Distribution business' continued dependence upon
pharmaceutical price inflation, which price inflation is often
unpredictable, either as a component of compensation from a
distribution service agreement or as the sole form of compensation
from certain branded pharmaceutical manufacturers;
- changes in the distribution or outsourcing pattern for
pharmaceutical and medical/surgical products and services, including
an increase in direct distribution or a decrease in contract
packaging by pharmaceutical manufacturers;
- the costs, difficulties, and uncertainties related to the
integration of acquired businesses, including liabilities related to
the operations or activities of such businesses prior to their
acquisition;
- changes to the presentation of financial results and position
resulting from adoption of new accounting principles or upon the
advice of the Company's independent accountants or the staff of the
SEC;
- weaknesses or deficiencies in internal controls and procedures
including those arising in connection with Section 404 of the
Sarbanes-Oxley Act of 2002;
- difficulties and costs associated with enhancing the Company's
accounting systems and internal controls and complying with
financial reporting requirements;
- changes in government regulations or the Company's failure to comply
with those regulations or other applicable laws;
- the results, effects or timing of any internal or external inquiry
or investigation, including those by any regulatory authority and
any related legal and administrative proceedings, which may include
the institution of administrative, civil injunctive or criminal
proceedings against the Company and/or current or former Company
employees, officers and/or directors, as well as the imposition of
fines and penalties, suspensions or debarments from government
contracting, and/or other remedies and sanctions;
- the impact of previously announced restatements;
- the costs and effects of commercial disputes, shareholder claims,
derivative claims or other legal proceedings;
- the costs, effects, timing or success of restructuring programs or
plans;
- downgrades of the Company's credit ratings, and the potential that
such downgrades could negatively impact the Company's access to
capital or increase the Company's cost of capital;
- increased costs for the raw materials used by the Company's
manufacturing businesses or shortages in these raw materials, or
increased fuel costs with respect to its distribution businesses;
- the risks of counterfeit products in the supply chain;
- the possible adverse effects on the Company of the importation of
pharmaceuticals and/or other health care products;
- injury to person or property resulting from the Company's
manufacturing, compounding, packaging, repackaging, drug delivery
system development and manufacturing, information systems, or
pharmacy management services;
- competitive factors in the Company's healthcare service businesses,
including pricing pressures;
- unforeseen changes in the Company's existing agency and distribution
arrangements;
- the continued financial viability and success of the Company's
customers, suppliers, and franchisees;
- difficulties encountered by the Company's competitors, whether or
not the Company faces the same or similar issues;
- technological developments and products offered by competitors;
- failure to retain or continue to attract senior management or key
personnel;
- uncertainties related to transitions in senior management positions;
- with respect to future dividends, the decision by the board of
directors to declare such dividends, which is expected to consider
the Company's surplus, earnings, cash flows, financial condition and
prospects at the time any such action is considered;
- with respect to future share repurchases, the approval of the board
of directors, which is expected to consider the Company's
then-current stock price, earnings,
cash flows, financial condition and prospects as well as
alternatives available to the Company at the time any such action is
considered;
- risks associated with international operations, including
fluctuations in currency exchange ratios;
- costs associated with protecting the Company's trade secrets and
enforcing its patent, copyright and trademark rights, and successful
challenges to the validity of its patents, copyrights or trademarks;
- difficulties or delays in the development, production,
manufacturing, and marketing of new products and services, including
difficulties or delays associated with obtaining requisite
regulatory consents or approvals associated with those activities or
the failure of the Company to adequately comply with applicable
regulations and quality practices or standards;
- potential liabilities associated with warranties of the Company's
information systems, and the malfunction or failure of the Company's
information systems or those of third parties with whom the Company
do business, such as malfunctions or failures associated with
date-related issues, incompatible software, improper coding and
disruption to internet-related operations;
- strikes or other labor disruptions;
- labor, pension and employee benefit costs;
- changes in hospital buying groups or hospital buying practices; and
- other factors described in the Company's Annual Report on Form 10-K,
Summary Annual Report to Shareholders, Quarterly Reports on Form
10-Q or the other documents the Company files with the SEC
including, but not limited to, the section entitled "Risk Factors
That May Affect Future Results" in the Company's Annual Report on
Form 10-K.
The words "believe," "expect," "anticipate," "project," and similar expressions
generally identify "forward-looking statements," which speak only as of the date
the statement was made. The Company undertakes no obligation (nor does it
intend) to publicly update or revise any forward-looking statements, whether as
a result of new information, future events or otherwise, except to the extent
required under applicable law.
Exhibit 99.02
FIRST AMENDMENT
TO THE
CARDINAL HEALTH 401(K) SAVINGS PLAN
(As amended and restated January 1, 2005)
BACKGROUND INFORMATION
A. Cardinal Health, Inc. ("Cardinal Health") established and maintains the
Cardinal Health 401(k) Savings Plan (the "Plan") for the benefit of
participants and their beneficiaries.
B. The Cardinal Health, Inc. Financial Benefit Plans Committee (the
"Committee") oversees the administration of the Plan and is authorized to
amend the Plan.
C. The Committee desires to amend the Plan to clarify a variety of existing
provisions and to more fully describe certain grandfathered benefits
retained from prior merging plans.
D. The Committee also desires to amend the Plan to permit continued
participant loan payments after a designated reduction in force and
otherwise to clarify the treatment of outstanding participant loan balances
after termination of employment and in other circumstances.
E. Section 12.02 of the Plan permits the amendment of the Plan at any time.
AMENDMENT OF THE PLAN
The Plan is hereby amended as follows, effective as of January 1, 2005
unless another date is set forth below:
1. Section 1.14 of the Plan is hereby amended in its entirety to read as
follows:
Section 1.14. Eligible Employee. Any Employee other than (a) an
Employee who may be excluded from participation pursuant to Code Section
410(b)(3) as a nonresident alien or as an Employee covered by a collective
bargaining agreement recognized as such under applicable federal labor law
and which does not expressly provide for participation in the Plan by
Employees covered thereunder, (b) an Employee who is (i) a resident of
Puerto Rico, (ii) working in Puerto Rico, (iii) paid on the payroll of a
Puerto Rico location of the Company or a Related Employer, and (iv)
eligible to participate in the Cardinal Health 401(k) Savings Plan for
Employees of Puerto Rico, (c) an Employee of an Employer (including, but
not limited to, Cardinal Health 109, Inc.) classified as a non-regular
"PRN" or on-call Employee, (d) an Employee of Mediqual Systems, Inc.
classified as an On-Demand Data Extractor or On-Demand Data Entry employee,
or (e) an Employee hired on a short-term basis, such as an intern. An
Eligible Employee may become a Participant in the Plan pursuant to the
requirements of Article II.
2. Section 5.02(B) of the Plan is hereby amended to read as follows:
Consent. The Participant must consent in writing to a distribution
(including the form of the distribution) if: (i) the Participant's
Nonforfeitable Account Balance on the date the distribution commences
exceeds $1,000 ($5,000 or less prior to March 28, 2005), and (ii) the
Administrative Committee directs the Trustee to make a distribution to the
Participant prior to his attaining the later of Normal Retirement Age or
age 62. Furthermore, the Participant's Spouse must consent in writing to
the distribution if: (i) the Participant's Nonforfeitable Account Balance
on the date the distribution commences exceeds $5,000; and (ii) the
qualified joint and survivor annuity provisions of Code Section 401(a)(11)
(as set forth in Schedule III of the Plan) apply to the distribution.
3. The introductory clause of Section 5.02(C) of the Plan is amended to read
as follows:
Time of Distribution of Account Balance. Upon Separation from Service,
other than for death, before Normal Retirement Age, and subject to the
consent requirements set forth in Schedule III to the Plan, the
Participant's Account balance shall be distributed as follows:
4. Section 6.06(E) of the Plan is amended in its entirety to read as follows:
Repayment Terms. The terms and conditions of each loan shall be determined
by mutual agreement between the Administrative Committee or Trustee and the
Participant. The Administrative Committee shall take all necessary actions
to ensure that each loan is repaid on schedule by its maturity date,
including requiring repayment of the loan by payroll deduction whenever
possible. However, notwithstanding the foregoing provisions of this Section
6.06.E., if a Participant is terminated from employment under the terms of
a designated reduction in force, the Participant may continue to make loan
payments on any loan balance outstanding at the time of such termination
according to the procedures adopted by the Administrative Committee.
5. Section 6.06(I) of the Plan is amended in its entirety to read as follows:
Failure to make a payment within 90 days of the date payment is due will
generally constitute a default, unless loan procedures adopted pursuant to
this Section 6.06 and applicable law do not so require. The Administrative
Committee may establish additional rules and procedures for handling loan
defaults, including, but not limited to, restrictions on future borrowing.
6. The first sentence of Section 8.09(iv) of the Plan is hereby amended in its
entirety to read as follows:
That any appeal the Claimant wishes to make of the adverse determination
must be in writing to the Benefits Group within 90 days after receipt of
the notice of denial of benefits.
7. Schedule V to the Plan is hereby amended in its entirety to read as set
forth in Exhibit A hereto.
8. All other Plan provisions shall remain in full force and effect.
CARDINAL HEALTH, INC.
By: /s/ Susan Nelson
------------------------------------
Susan Nelson
Its: Vice President - Compensation and
Benefits
Date: June 13, 2005
SCHEDULE V
SPECIAL PROVISIONS FOR PRIOR MERGED PLANS
A. Special Rules Regarding Participants in the Owen Healthcare, Inc. 401(k)
Savings Plan.
(i) A Participant employed by Owen Healthcare, Inc. ("Owen") on June 30,
1998 shall, to the extent applicable, continue to have a separate
After-tax Contribution Account and a separate Participant IRA Account
under the Plan.
(ii) A Participant employed by Owen on June 30, 1998 shall continue to be
permitted to obtain in-service withdrawals from his after-tax
contributions Account.
(iii) A Participant employed by Owen on June 30, 1998 shall continue to be
permitted to obtain in-service withdrawals from his Participant IRA
Account in an amount equal to all, but not less than all, of the
amounts held in such Participant IRA Account.
B. Special Rules Regarding Participants in the Packaging Coordinators, Inc.
Money Purchase Pension Plan. Participants employed by Packaging
Coordinators, Inc. on June 30, 1998 shall continue to have the option to
receive distributions from the Plan in the form of a 100% Qualified Joint
and Survivor Annuity, to the extent applicable, or in the form of a single
life annuity. A single life annuity shall continue to be the normal form of
benefit payable to an unmarried Participant.
C. Transition Contribution for Participants in the R.P. Scherer Employees'
Retirement Income Plan. The Employer shall make a Transition Contribution
on behalf of an Employee of Cardinal Health 409, Inc. (f/k/a R.P. Scherer
Corporation) who:
(i) was a Participant in the R.P. Scherer Corporation Employees'
Retirement Income Plan (the "Pension Plan") on December 31, 2002;
(ii) completed at least five (5) Years of Service on or before December 31,
2002;
(iii) attained at least age fifty (50) on or before December 31, 2002; and
(iv) are employed by Cardinal Health 409, Inc. on the last day of the
applicable Fiscal Year.
The amount of the Transition Benefit shall be a percentage of Compensation
based on the Participant's Years of Service in the Pension Plan as of
December 31, 2002:
Transition Benefit
Years of Service (as of 12/31/02) Percentage
--------------------------------- ------------------
Less than five (5) 0%
At least five (5) but less than 10 (ten) 1.5%
At least ten (10) but less than fifteen (15) 3.5%
At least fifteen (15) but less than twenty (20) 5.5%
At least twenty (20) but less than twenty-five (25) 7.5%
Twenty-five (25) or more 9.5%
The Transition Benefit shall be contributed to the Participant's Account
for each Fiscal Year in which the Participant satisfies the criteria set
forth in this subsection (b) beginning on January 1, 2003 and ending on
December 31, 2008.
Compensation issued to determine the amount of the Transition Benefit for
an applicable Fiscal Year shall be based on the following periods:
Fiscal Year Period Used to Determine Compensation
----------- -------------------------------------
2003 January 1, 2003 to June 30, 2003
2004 July 1, 2003 to June 30, 2004
2005 July 1, 2004 to June 30, 2005
2006 July 1, 2005 to June 30, 2006
2007 July 1, 2006 to June 30, 2007
2008 July 1, 2007 to June 30, 2008
2009 July 1, 2008 to December 31, 2008
D. Special Rules Regarding Active Employees of Medical Products and Services
(f/k/a Allegiance Corporation).
(i) For purposes of Employer Contributions under the Plan, the term
"Compensation" shall mean "Base Pay" until July 1, 2005 defined as
follows:
1. With respect to Employees who are compensated based upon sales
commissions and with greater than 25% of pay at risk, Base Pay
includes 75% of the Employee's regular pay, draw and commissions
for the Plan Year, but excludes shift differentials, exception
pay, Management Incentive Compensation Plan ("MICP"), lump sum
merit pay, expenses, performance pay and any other payments
2. With respect to Employees who are not compensated based upon
sales commissions or who are paid commissions but with less than
25% of pay at risk, Base Pay includes regular pay, back pay,
vacation pay, holiday
pay, sick pay, funeral pay, jury pay, military pay and other paid
absences, but excludes overtime, short-term disability, shift
differential, exception pay, MICP, lump sum merit pay,
performance pay and any other payments.
(ii) A Participant who (1) was employed by Allegiance Corporation prior to
January 1, 2001, (2) is fully vested in his Non-Safe Harbor Matching
Contributions and Employer Contributions Accounts, and (3) has
attained his fifth anniversary of participation may elect to withdraw
any or all of his Matching Contributions or amounts held in his Profit
Sharing Account at any time. A Participant who elects to make such a
withdrawal is ineligible to make Compensation Deferral Contributions
for a period of six months commencing on the first day of the first
calendar month following the date on which the accounts are valued for
purposes of making such withdrawal. Such Participant's Compensation
Deferral Contributions shall recommence at the same rate (unless the
Participant elects otherwise) on the first day of the sixth full
calendar month following the date of the commencement of the
suspension.
E. Special Rules Regarding Former Participants in the Alaris Medical Systems
Retirement Investment Plan. A Participant may withdraw all or part of his
interest held in the Alaris Medical Systems Retirement Investment Plan
credited prior to December 31, 1997, excluding earnings credited after
December 31, 1997 and Pre-Tax Contributions, at any time. In addition to
any other rules the Administrative Committee may prescribe, such
withdrawals shall be limited to one withdrawal per Plan Year in a whole
dollar amount of $500 or more.
F. Non-Highly Compensated Employees Subject to a Reduction in Force. A
Non-highly Compensated Employee who has completed one full year of Service
but less than three years of Service and is terminated from employment
under the terms of a designated reduction in force shall receive additional
vesting service under Section 4.01.A of the Plan.
The Participant's Account balance reflecting such additional vesting shall
be calculated by multiplying the portion of his or her Account balance that
is subject to the vesting provisions of Section 4.01 by a fraction, the
numerator of which is the Participant's calendar months of Service
calculated from his or her date of hire and the denominator of which is 36,
and by rounding the product up to the next whole percentage. A month of
Service shall be included in the calculation of additional vesting service
under this Section if the Participant has performed at least one Hour of
Service during the calendar month. In no event shall a Participant be more
than 100% vested in any amounts in his Accounts.
Exhibit 99.03
FIRST AMENDMENT
TO THE
CARDINAL HEALTH 401(K) SAVINGS PLAN
FOR EMPLOYEES OF PUERTO RICO
(As amended and restated January 1, 2005)
BACKGROUND INFORMATION
A. Cardinal Health, Inc. maintains a retirement plan known as the Cardinal
Health 401(k) Savings Plan for Employees of Puerto Rico (the "Plan") for the
benefit of eligible employees who live and work in Puerto Rico.
B. The Cardinal Health Financial Benefit Plans Committee (the "Committee")
oversees the administration of the Plan and is authorized to amend the Plan.
C. The Committee desires to amend the Plan to clarify certain eligibility
provisions.
D. The Committee also desires to amend the plan to reflect the vesting
applicable to certain employees upon a designated reduction in force.
E. The Committee also desires to amend the Plan to permit continued participant
loan payments after a designated reduction in force and to otherwise clarify the
treatment of outstanding participant loan balances after termination of
employment and in other circumstances.
F. Section 11.02 of the Plan permits the amendment of the Plan at any time.
AMENDMENT OF THE PLAN
The Plan is hereby amended as follows, effective as of the dates indicated
below:
1. Effective January 1, 2005, Section 1.13(d) is hereby amended to read as
follows in its entirety:
"(d) an Employee hired on a short-term basis, such as an intern."
2. Effective June 1, 2005, a new last paragraph is hereby added to Section 4.01
of the Plan to read in its entirety as follows:
Notwithstanding the foregoing provisions of Section 4.01 or any
applicable Appendix, a Participant who has completed one full Year of
Service but less than three Years of Service and who is terminated from
employment under the terms of a designated reduction in force shall receive
additional vesting service under this Section 4.01 of the Plan. The
Participant's Account balance reflecting such additional vesting shall be
calculated by multiplying the portion of his Account balance that is
subject to the vesting provisions of Section 4.01 by a fraction, the
numerator of which is the Participant's calendar months of Service
calculated from his or her Employment Commencement Date and the denominator
of which is 36, and by rounding the product up to the next whole
percentage. A month of Service shall be included in the calculation of
additional vesting service under this Section if the Participant has
performed at least one Hour of Service during the calendar month. In no
event shall a Participant be more than 100% vested in any amounts in his
Account.
3. Effective January 1, 2005, Section 6.05.E. of the Plan is amended in its
entirety to read as follows:
The terms and conditions of each loan shall be determined by mutual
agreement between the Administrative Committee or Trustee and the
Participant. The Administrative Committee shall adopt such procedures and
take all necessary actions to ensure that each loan is repaid on schedule
by its maturity date, including requiring repayment of the loan by payroll
deduction whenever possible. However, notwithstanding the foregoing
provisions of this Section 6.05.E., if a Participant is terminated from
employment under the terms of a designated reduction in force, the
Participant may continue to make loan payments on any loan balance
outstanding at the time of such termination according to the procedures
adopted by the Administrative Committee.
4. Effective January 1, 2005, Section 6.05.I. of the Plan is hereby amended in
its entirety to read as follows:
Failure to make a payment within 90 days of the date payment is due will
generally constitute a default, unless loan procedures adopted pursuant to
this Section 6.05 and applicable law do not so require. The Administrative
Committee may establish additional rules and procedures for handling loan
defaults, including, but not limited to, restrictions on future borrowing.
5. All other provisions and terms of the Plan shall remain in full force and
effect.
CARDINAL HEALTH, INC.
BY: /s/ Susan M. Nelson
------------------------------------
Susan M. Nelson
ITS: Vice President - Compensation and
Benefits
DATE: June 13, 2005